| Year |
Citation |
Score |
| 2023 |
Kanekiyo M, Gillespie RA, Midgett M, O'Malley KJ, Williams C, Moin SM, Wallace M, Treaster L, Cooper K, Syeda H, Kettenburg G, Rannulu H, Schmer T, Ortiz L, Da Silva Castanha P, ... ... Graham BS, et al. Refined semi-lethal aerosol H5N1 influenza model in cynomolgus macaques for evaluation of medical countermeasures. Iscience. 26: 107830. PMID 37766976 DOI: 10.1016/j.isci.2023.107830 |
0.359 |
|
| 2023 |
McCool RS, Musayev M, Bush SM, Derrien-Colemyn A, Acreman CM, Wrapp D, Ruckwardt TJ, Graham BS, Mascola JR, McLellan JS. Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope. Journal of Virology. e0092923. PMID 37737588 DOI: 10.1128/jvi.00929-23 |
0.36 |
|
| 2023 |
Krug PW, Wang L, Shi W, Kong WP, Moss DL, Yang ES, Fisher BE, Morabito KM, Mascola JR, Kanekiyo M, Graham BS, Ruckwardt TJ. EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination. Science Advances. 9: eadg6076. PMID 37196074 DOI: 10.1126/sciadv.adg6076 |
0.361 |
|
| 2023 |
Bollman B, Nunna N, Bahl K, Hsiao CJ, Bennett H, Butler S, Foreman B, Burgomaster KE, Aleshnick M, Kong WP, Fisher BE, Ruckwardt TJ, Morabito KM, Graham BS, Dowd KA, et al. An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection. Npj Vaccines. 8: 58. PMID 37080988 DOI: 10.1038/s41541-023-00656-4 |
0.309 |
|
| 2023 |
Widge AT, Hofstetter AR, Houser KV, Awan SF, Chen GL, Burgos Florez MC, Berkowitz NM, Mendoza F, Hendel CS, Holman LA, Gordon IJ, Apte P, Liang CJ, Gaudinski MR, Coates EE, ... ... Graham BS, et al. An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults. Science Translational Medicine. 15: eade4790. PMID 37075129 DOI: 10.1126/scitranslmed.ade4790 |
0.33 |
|
| 2023 |
Peretti A, Scorpio DG, Kong WP, Pang YS, McCarthy MP, Ren K, Jackson M, Graham BS, Buck CB, McTamney PM, Pastrana DV. A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaques. Vaccine. PMID 36764908 DOI: 10.1016/j.vaccine.2023.02.002 |
0.334 |
|
| 2022 |
Chang LA, Phung E, Crank MC, Morabito KM, Villafana T, Dubovsky F, Falloon J, Esser MT, Lin BC, Chen GL, Graham BS, Ruckwardt TJ. A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine. Science Translational Medicine. 14: eade0424. PMID 36542692 DOI: 10.1126/scitranslmed.ade0424 |
0.311 |
|
| 2022 |
Milligan EC, Olstad K, Williams CA, Mallory M, Cano P, Cross KA, Munt JE, Garrido C, Lindesmith L, Watanabe J, Usachenko JL, Hopkins L, Immareddy R, Lakshmanappa YS, Elizaldi SR, ... ... Graham BS, et al. Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later. Science Translational Medicine. eadd6383. PMID 36454813 DOI: 10.1126/scitranslmed.add6383 |
0.355 |
|
| 2022 |
Moin SM, Boyington JC, Boyoglu-Barnum S, Gillespie RA, Cerutti G, Cheung CS, Cagigi A, Gallagher JR, Brand J, Prabhakaran M, Tsybovsky Y, Stephens T, Fisher BE, Creanga A, Ataca S, ... ... Graham BS, et al. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses. Immunity. PMID 36356572 DOI: 10.1016/j.immuni.2022.10.015 |
0.343 |
|
| 2022 |
McMahon M, O'Dell G, Tan J, Sárközy A, Vadovics M, Carreño JM, Puente-Massaguer E, Muramatsu H, Bajusz C, Rijnink W, Beattie M, Tam YK, Kirkpatrick Roubidoux E, Francisco I, Strohmeier S, ... ... Graham BS, et al. Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses. Proceedings of the National Academy of Sciences of the United States of America. 119: e2206333119. PMID 36322769 DOI: 10.1073/pnas.2206333119 |
0.372 |
|
| 2022 |
Clemens EA, Holbrook BC, McNeilly B, Kanekiyo M, Graham BS, Alexander-Miller MA. TLR agonists induce sustained IgG to hemagglutinin stem and modulate T cells following newborn vaccination. Npj Vaccines. 7: 102. PMID 36038596 DOI: 10.1038/s41541-022-00523-8 |
0.343 |
|
| 2022 |
Mazur NI, Terstappen J, Baral R, Bardají A, Beutels P, Buchholz UJ, Cohen C, Crowe JE, Cutland CL, Eckert L, Feikin D, Fitzpatrick T, Fong Y, Graham BS, Heikkinen T, et al. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. The Lancet. Infectious Diseases. PMID 35952703 DOI: 10.1016/S1473-3099(22)00291-2 |
0.368 |
|
| 2022 |
van Haren SD, Pedersen GK, Kumar A, Ruckwardt TJ, Moin S, Moore IN, Minai M, Liu M, Pak J, Borriello F, Doss-Gollin S, Beijnen EMS, Ahmed S, Helmel M, Andersen P, ... Graham BS, et al. CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns. Nature Communications. 13: 4234. PMID 35918315 DOI: 10.1038/s41467-022-31709-2 |
0.373 |
|
| 2022 |
Phung E, Chang LA, Mukhamedova M, Yang L, Nair D, Rush SA, Morabito KM, McLellan JS, Buchholz UJ, Mascola JR, Crank MC, Chen G, Graham BS, Ruckwardt TJ. Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine. Science Translational Medicine. 14: eabo5032. PMID 35731888 DOI: 10.1126/scitranslmed.abo5032 |
0.309 |
|
| 2022 |
Houser KV, Chen GL, Carter C, Crank MC, Nguyen TA, Burgos Florez MC, Berkowitz NM, Mendoza F, Hendel CS, Gordon IJ, Coates EE, Vazquez S, Stein J, Case CL, Lawlor H, ... ... Graham BS, et al. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial. Nature Medicine. PMID 35115706 DOI: 10.1038/s41591-021-01660-8 |
0.303 |
|
| 2021 |
Gagne M, Corbett KS, Flynn BJ, Foulds KE, Wagner DA, Andrew SF, Todd JM, Honeycutt CC, McCormick L, Nurmukhambetova ST, Davis-Gardner ME, Pessaint L, Bock KW, Nagata BM, Minai M, ... ... Graham BS, et al. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung. Cell. PMID 34921774 DOI: 10.1016/j.cell.2021.12.002 |
0.326 |
|
| 2021 |
Gagne M, Corbett KS, Flynn BJ, Foulds KE, Wagner DA, Andrew SF, Todd JM, Honeycutt CC, McCormick L, Nurmukhambetova ST, Davis-Gardner ME, Pessaint L, Bock KW, Nagata BM, Minai M, ... ... Graham BS, et al. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway. Biorxiv : the Preprint Server For Biology. PMID 34729558 DOI: 10.1101/2021.10.23.465542 |
0.323 |
|
| 2021 |
Hsieh CL, Werner AP, Leist SR, Stevens LJ, Falconer E, Goldsmith JA, Chou CW, Abiona OM, West A, Westendorf K, Muthuraman K, Fritch EJ, Dinnon KH, Schäfer A, Denison MR, ... ... Graham BS, et al. Stabilized coronavirus spike stem elicits a broadly protective antibody. Cell Reports. 109929. PMID 34710354 DOI: 10.1016/j.celrep.2021.109929 |
0.303 |
|
| 2021 |
Meyer M, Wang Y, Edwards D, Smith GR, Rubenstein AB, Ramanathan P, Mire CE, Pietzsch C, Chen X, Ge Y, Cheng WS, Henry C, Woods A, Ma L, Stewart-Jones GB, ... ... Graham BS, et al. Attenuated activation of pulmonary immune cells in mRNA-1273 vaccinated hamsters after SARS-CoV-2 infection. The Journal of Clinical Investigation. PMID 34449440 DOI: 10.1172/JCI148036 |
0.357 |
|
| 2021 |
Francica JR, Flynn BJ, Foulds KE, Noe AT, Werner AP, Moore IN, Gagne M, Johnston TS, Tucker C, Davis RL, Flach B, O'Connell S, Andrew SF, Lamb E, Flebbe DR, ... ... Graham BS, et al. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Science Translational Medicine. PMID 34315825 DOI: 10.1126/scitranslmed.abi4547 |
0.375 |
|
| 2021 |
DiPiazza AT, Leist SR, Abiona OM, Moliva JI, Werner A, Minai M, Nagata BM, Bock KW, Phung E, Schäfer A, Dinnon KH, Chang LA, Loomis RJ, Boyoglu-Barnum S, Alvarado GS, ... ... Graham BS, et al. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity. PMID 34270939 DOI: 10.1016/j.immuni.2021.06.018 |
0.373 |
|
| 2021 |
Edara VV, Pinsky BA, Suthar MS, Lai L, Davis-Gardner ME, Floyd K, Flowers MW, Wrammert J, Hussaini L, Ciric CR, Bechnak S, Stephens K, Graham BS, Bayat Mokhtari E, Mudvari P, et al. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants. The New England Journal of Medicine. PMID 34233096 DOI: 10.1056/NEJMc2107799 |
0.346 |
|
| 2021 |
Garrido C, Curtis AD, Dennis M, Pathak SH, Gao H, Montefiori D, Tomai M, Fox CB, Kozlowski PA, Scobey T, Munt JE, Mallory ML, Saha PT, Hudgens MG, Lindesmith LC, ... ... Graham B, et al. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. Science Immunology. 6. PMID 34131024 DOI: 10.1126/sciimmunol.abj3684 |
0.321 |
|
| 2021 |
Taleb SA, Al-Ansari K, Nasrallah GK, Elrayess MA, Al-Thani AA, Derrien-Colemyn A, Ruckwardt TJ, Graham BS, Yassine HM. Level of Maternal Respiratory Syncytial Virus (RSV) F Antibodies in Hospitalized Children and Correlates of Protection. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 34118428 DOI: 10.1016/j.ijid.2021.06.015 |
0.302 |
|
| 2021 |
Edara VV, Lai L, Sahoo MK, Floyd K, Sibai M, Solis D, Flowers MW, Hussaini L, Ciric CR, Bechnack S, Stephens K, Mokhtari EB, Mudvari P, Creanga A, Pegu A, ... ... Graham BS, et al. Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant. Biorxiv : the Preprint Server For Biology. PMID 34013272 DOI: 10.1101/2021.05.09.443299 |
0.348 |
|
| 2021 |
Burgomaster KE, Foreman BM, Aleshnick MA, Larman BC, Gordon DN, Maciejewski S, Morabito KM, Ledgerwood JE, Gaudinski MR, Chen GL, Mascola JR, Debbink K, Dowd KA, Graham BS, Pierson TC. Limited flavivirus cross-reactive antibody responses elicited by a ZIKV DNA vaccine candidate in humans. The Journal of Infectious Diseases. PMID 33961055 DOI: 10.1093/infdis/jiab185 |
0.343 |
|
| 2021 |
Corbett KS, Nason MC, Flach B, Gagne M, O' Connell S, Johnston TS, Shah SN, Edara VV, Floyd K, Lai L, McDanal C, Francica JR, Flynn B, Wu K, Choi A, ... ... Graham BS, et al. Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates. Biorxiv : the Preprint Server For Biology. PMID 33907752 DOI: 10.1101/2021.04.20.440647 |
0.351 |
|
| 2021 |
Ruckwardt TJ, Morabito KM, Phung E, Crank MC, Costner PJ, Holman LA, Chang LA, Hickman SP, Berkowitz NM, Gordon IJ, Yamshchikov GV, Gaudinski MR, Lin B, Bailer R, Chen M, ... ... Graham BS, et al. Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial. The Lancet. Respiratory Medicine. PMID 33864736 DOI: 10.1016/S2213-2600(21)00098-9 |
0.343 |
|
| 2021 |
Garrido C, Curtis AD, Dennis M, Pathak SH, Gao H, Montefiori D, Tomai M, Fox CB, Kozlowski PA, Scobey T, Munt JE, Mallroy ML, Saha PT, Hudgens MG, Lindesmith LC, ... ... Graham B, et al. SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus Macaques. Biorxiv : the Preprint Server For Biology. PMID 33851156 DOI: 10.1101/2021.04.05.438479 |
0.303 |
|
| 2021 |
Mukhamedova M, Wrapp D, Shen CH, Gilman MSA, Ruckwardt TJ, Schramm CA, Ault L, Chang L, Derrien-Colemyn A, Lucas SAM, Ransier A, Darko S, Phung E, Wang L, Zhang Y, ... ... Graham BS, et al. Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses. Immunity. PMID 33823129 DOI: 10.1016/j.immuni.2021.03.004 |
0.356 |
|
| 2021 |
Jones BE, Brown-Augsburger PL, Corbett KS, Westendorf K, Davies J, Cujec TP, Wiethoff CM, Blackbourne JL, Heinz BA, Foster D, Higgs RE, Balasubramaniam D, Wang L, Zhang Y, Yang ES, ... ... Graham BS, et al. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in non-human primates. Science Translational Medicine. PMID 33820835 DOI: 10.1126/scitranslmed.abf1906 |
0.333 |
|
| 2021 |
Boyoglu-Barnum S, Ellis D, Gillespie RA, Hutchinson GB, Park YJ, Moin SM, Acton OJ, Ravichandran R, Murphy M, Pettie D, Matheson N, Carter L, Creanga A, Watson MJ, Kephart S, ... ... Graham BS, et al. Quadrivalent influenza nanoparticle vaccines induce broad protection. Nature. PMID 33762730 DOI: 10.1038/s41586-021-03365-x |
0.337 |
|
| 2021 |
Creanga A, Gillespie RA, Fisher BE, Andrews SF, Lederhofer J, Yap C, Hatch L, Stephens T, Tsybovsky Y, Crank MC, Ledgerwood JE, McDermott AB, Mascola JR, Graham BS, Kanekiyo M. A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies. Nature Communications. 12: 1722. PMID 33741916 DOI: 10.1038/s41467-021-21954-2 |
0.357 |
|
| 2021 |
Francica JR, Flynn BJ, Foulds KE, Noe AT, Werner AP, Moore IN, Gagne M, Johnston TS, Tucker C, Davis RL, Flach B, O'Connell S, Andrew SF, Lamb E, Flebbe DR, ... ... Graham BS, et al. Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates. Biorxiv : the Preprint Server For Biology. PMID 33688652 DOI: 10.1101/2021.03.02.433390 |
0.4 |
|
| 2021 |
Darricarrère N, Qiu Y, Kanekiyo M, Creanga A, Gillespie RA, Moin SM, Saleh J, Sancho J, Chou TH, Zhou Y, Zhang R, Dai S, Moody A, Saunders KO, Crank MC, ... ... Graham BS, et al. Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates. Science Translational Medicine. 13. PMID 33658355 DOI: 10.1126/scitranslmed.abe5449 |
0.347 |
|
| 2021 |
Meyer M, Wang Y, Edwards D, Smith GR, Rubenstein AB, Ramanathan P, Mire CE, Pietzsch C, Chen X, Ge Y, Cheng WS, Henry C, Woods A, Ma L, Stewart-Jones GBE, ... ... Graham BS, et al. mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge. Biorxiv : the Preprint Server For Biology. PMID 33532780 DOI: 10.1101/2021.01.25.428136 |
0.332 |
|
| 2021 |
Yang Y, Shi W, Abiona OM, Nazzari A, Olia AS, Ou L, Phung E, Stephens T, Tsybovsky Y, Verardi R, Wang S, Werner A, Yap C, Ambrozak D, Bylund T, ... ... Graham BS, et al. Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses. Vaccines. 9. PMID 33494381 DOI: 10.3390/vaccines9020073 |
0.325 |
|
| 2021 |
Li D, Edwards RJ, Manne K, Martinez DR, Schäfer A, Alam SM, Wiehe K, Lu X, Parks R, Sutherland LL, Oguin TH, McDanal C, Perez LG, Mansouri K, Gobeil SMC, ... ... Graham BS, et al. The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates. Biorxiv : the Preprint Server For Biology. PMID 33442694 DOI: 10.1101/2020.12.31.424729 |
0.31 |
|
| 2020 |
Clemens EA, Holbrook BC, Kanekiyo M, Yewdell JW, Graham BS, Alexander-Miller MA. An R848 conjugated influenza virus vaccine elicits robust IgG to hemagglutinin stem in a newborn nonhuman primate model. The Journal of Infectious Diseases. PMID 33245745 DOI: 10.1093/infdis/jiaa728 |
0.396 |
|
| 2020 |
DiPiazza AT, Graham BS, Ruckwardt TJ. T cell immunity to SARS-CoV-2 following natural infection and vaccination. Biochemical and Biophysical Research Communications. PMID 33190827 DOI: 10.1016/j.bbrc.2020.10.060 |
0.367 |
|
| 2020 |
Muñoz-Fontela C, Dowling WE, Funnell SGP, Gsell PS, Balta XR, Albrecht RA, Andersen H, Baric RS, Carroll MW, Cavaleri M, Qin C, Crozier I, Dallmeier K, de Waal L, de Wit E, ... ... Graham BS, et al. Animal models for COVID-19. Nature. PMID 32967005 DOI: 10.1038/s41586-020-2787-6 |
0.318 |
|
| 2020 |
Luisi K, Morabito KM, Burgomaster KE, Sharma M, Kong WP, Foreman BM, Patel S, Fisher B, Aleshnick MA, Laliberte J, Wallace M, Ruckwardt TJ, Gordon DN, Linton C, Ruggiero N, ... ... Graham BS, et al. Development of a potent Zika virus vaccine using self-amplifying messenger RNA. Science Advances. 6: eaba5068. PMID 32821824 DOI: 10.1126/Sciadv.Aba5068 |
0.35 |
|
| 2020 |
Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, Himansu S, Schäfer A, Ziwawo CT, DiPiazza AT, Dinnon KH, Elbashir SM, Shaw CA, Woods A, Fritch EJ, ... ... Graham BS, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. PMID 32756549 DOI: 10.1038/S41586-020-2622-0 |
0.411 |
|
| 2020 |
Corbett KS, Flynn B, Foulds KE, Francica JR, Boyoglu-Barnum S, Werner AP, Flach B, O'Connell S, Bock KW, Minai M, Nagata BM, Andersen H, Martinez DR, Noe AT, Douek N, ... ... Graham BS, et al. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates. The New England Journal of Medicine. PMID 32722908 DOI: 10.1056/Nejmoa2024671 |
0.423 |
|
| 2020 |
Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, ... ... Graham BS, et al. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. The New England Journal of Medicine. PMID 32663912 DOI: 10.1056/Nejmoa2022483 |
0.39 |
|
| 2020 |
Loomis RJ, Stewart-Jones GBE, Tsybovsky Y, Caringal RT, Morabito KM, McLellan JS, Chamberlain AL, Nugent ST, Hutchinson GB, Kueltzo LA, Mascola JR, Graham BS. Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development. Frontiers in Immunology. 11: 842. PMID 32595632 DOI: 10.3389/Fimmu.2020.00842 |
0.438 |
|
| 2020 |
Wec AZ, Wrapp D, Herbert AS, Maurer DP, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang D, Tse LV, Johnson NV, Hsieh CL, Wang N, Nett JH, ... ... Graham BS, et al. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science (New York, N.Y.). PMID 32540900 DOI: 10.1126/Science.Abc7424 |
0.428 |
|
| 2020 |
Maciejewski S, Ruckwardt TJ, Morabito KM, Foreman BM, Burgomaster KE, Gordon DN, Pelc RS, DeMaso CR, Ko SY, Fisher BE, Yang ES, Nair D, Foulds KE, Todd JP, Kong WP, ... ... Graham BS, et al. Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality. Science Translational Medicine. 12. PMID 32522807 DOI: 10.1126/Scitranslmed.Aaw9066 |
0.373 |
|
| 2020 |
Wec AZ, Wrapp D, Herbert AS, Maurer D, Haslwanter D, Sakharkar M, Jangra RK, Dieterle ME, Lilov A, Huang D, Tse LV, Johnson NV, Hsieh CL, Wang N, Nett JH, ... ... Graham BS, et al. Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein. Biorxiv : the Preprint Server For Biology. PMID 32511337 DOI: 10.1101/2020.05.15.096511 |
0.325 |
|
| 2020 |
Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, et al. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine. PMID 32507409 DOI: 10.1016/J.Vaccine.2020.05.064 |
0.435 |
|
| 2020 |
Wei CJ, Crank MC, Shiver J, Graham BS, Mascola JR, Nabel GJ. Author Correction: Next-generation influenza vaccines: opportunities and challenges. Nature Reviews. Drug Discovery. 19: 427. PMID 32494049 DOI: 10.1038/S41573-020-0066-8 |
0.389 |
|
| 2020 |
Buchwald AG, Graham BS, Traore A, Haidara FC, Chen M, Morabito K, Lin BC, Sow SO, Levine MM, Pasetti MF, Tapia MD. RSV neutralizing antibodies at birth predict protection from RSV illness in infants in the first three months of life. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32463443 DOI: 10.1093/Cid/Ciaa648 |
0.408 |
|
| 2020 |
Graham BS. Rapid COVID-19 vaccine development. Science (New York, N.Y.). PMID 32385100 DOI: 10.1126/Science.Abb8923 |
0.379 |
|
| 2020 |
Choi JH, Woo HM, Lee TY, Lee SY, Shim SM, Park WJ, Yang JS, Kim JA, Yun MR, Kim DW, Kim SS, Zhang Y, Shi W, Wang L, Graham BS, et al. Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus. Plos One. 15: e0232757. PMID 32384116 DOI: 10.1371/Journal.Pone.0232757 |
0.41 |
|
| 2020 |
Wrapp D, De Vlieger D, Corbett KS, Torres GM, Wang N, Van Breedam W, Roose K, van Schie L, Hoffmann M, Pöhlmann S, Graham BS, Callewaert N, Schepens B, Saelens X, et al. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell. PMID 32375025 DOI: 10.1016/J.Cell.2020.04.031 |
0.351 |
|
| 2020 |
Graham BS, Corbett KS. Prototype pathogen approach for pandemic preparedness: world on fire. The Journal of Clinical Investigation. PMID 32352406 DOI: 10.1172/Jci139601 |
0.32 |
|
| 2020 |
Chen GL, Coates EE, Plummer SH, Carter CA, Berkowitz N, Conan-Cibotti M, Cox JH, Beck A, O'Callahan M, Andrews C, Gordon IJ, Larkin B, Lampley R, Kaltovich F, Gall J, ... ... Graham BS, et al. Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial. Jama. 323: 1369-1377. PMID 32286643 DOI: 10.1001/Jama.2020.2477 |
0.437 |
|
| 2020 |
Kanekiyo M, Graham BS. Next-Generation Influenza Vaccines. Cold Spring Harbor Perspectives in Medicine. PMID 32229612 DOI: 10.1101/Cshperspect.A038448 |
0.427 |
|
| 2020 |
Clemens EA, Angeletti D, Holbrook BC, Kanekiyo M, Jorgensen MJ, Graham BS, Yewdell JW, Alexander-Miller MA. Influenza infected newborn and adult monkeys exhibit a strong primary antibody response to hemagglutinin stem. Jci Insight. PMID 32078584 DOI: 10.1172/Jci.Insight.135449 |
0.408 |
|
| 2020 |
Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (New York, N.Y.). PMID 32075877 DOI: 10.1126/Science.Abb2507 |
0.311 |
|
| 2020 |
Wei CJ, Crank MC, Shiver J, Graham BS, Mascola JR, Nabel GJ. Next-generation influenza vaccines: opportunities and challenges. Nature Reviews. Drug Discovery. PMID 32060419 DOI: 10.1038/S41573-019-0056-X |
0.455 |
|
| 2020 |
Liu X, Liang B, Liu X, Amaro-Carambot E, Surman S, Kwong PD, Graham BS, Collins PL, Munir S. Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates. Plos One. 15: e0228572. PMID 32045432 DOI: 10.1371/Journal.Pone.0228572 |
0.364 |
|
| 2020 |
Boyoglu-Barnum S, Hutchinson GB, Boyington JC, Moin SM, Gillespie RA, Tsybovsky Y, Stephens T, Vaile JR, Lederhofer J, Corbett KS, Fisher BE, Yassine HM, Andrews SF, Crank MC, McDermott AB, ... ... Graham BS, et al. Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses. Nature Communications. 11: 791. PMID 32034141 DOI: 10.1038/S41467-020-14579-4 |
0.375 |
|
| 2019 |
Joyce MG, Bao A, Chen M, Georgiev IS, Ou L, Bylund T, Druz A, Kong WP, Peng D, Rundlet EJ, Van Galen JG, Wang S, Yang Y, Zhang B, Chuang GY, ... ... Graham BS, et al. Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B. Pathogens & Immunity. 4: 294-323. PMID 31893251 DOI: 10.20411/pai.v4i2.338 |
0.37 |
|
| 2019 |
Van Rompay KKA, Keesler RI, Ardeshir A, Watanabe J, Usachenko J, Singapuri A, Cruzen C, Bliss-Moreau E, Murphy AM, Yee JL, Webster H, Dennis M, Singh T, Heimsath H, Lemos D, ... ... Graham BS, et al. DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomes. Science Translational Medicine. 11. PMID 31852797 DOI: 10.1126/Scitranslmed.Aay2736 |
0.449 |
|
| 2019 |
Menachery VD, Dinnon KH, Yount BL, McAnarney ET, Gralinski LE, Hale A, Graham RL, Scobey T, Anthony SJ, Wang L, Graham B, Randell SH, Lipkin WI, Baric RS. Trypsin treatment unlocks barrier for zoonotic bat coronaviruses infection. Journal of Virology. PMID 31801868 DOI: 10.1128/Jvi.01774-19 |
0.382 |
|
| 2019 |
Setliff I, Shiakolas AR, Pilewski KA, Murji AA, Mapengo RE, Janowska K, Richardson S, Oosthuysen C, Raju N, Ronsard L, Kanekiyo M, Qin JS, Kramer KJ, Greenplate AR, McDonnell WJ, ... Graham BS, et al. High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity. Cell. PMID 31787378 DOI: 10.1016/J.Cell.2019.11.003 |
0.381 |
|
| 2019 |
Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Van Tieu H, Allen M, Hural J, Graham BS, Kublin J, Gilbert PB, et al. Antigenic competition in CD4 T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial. Science Translational Medicine. 11. PMID 31748227 DOI: 10.1126/Scitranslmed.Aaw1673 |
0.453 |
|
| 2019 |
Cunningham CK, McFarland EJ, Morrison RL, Capparelli EV, Safrit JT, Mofenson LM, Mathieson B, Valentine ME, Perlowski C, Smith B, Hazra R, Purdue L, Muresan P, Harding PA, Mbengeranwa T, ... ... Graham BS, et al. Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants. The Journal of Infectious Diseases. PMID 31681963 DOI: 10.1093/Infdis/Jiz532 |
0.305 |
|
| 2019 |
Neidich SD, Fong Y, Li SS, Geraghty DE, Williamson BD, Young WC, Goodman D, Seaton KE, Shen X, Sawant S, Zhang L, deCamp AC, Blette BS, Shao M, Yates NL, ... ... Graham BS, et al. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk. The Journal of Clinical Investigation. PMID 31589165 DOI: 10.1172/Jci126391 |
0.403 |
|
| 2019 |
Sangesland M, Ronsard L, Kazer SW, Bals J, Boyoglu-Barnum S, Yousif AS, Barnes R, Feldman J, Quirindongo-Crespo M, McTamney PM, Rohrer D, Lonberg N, Chackerian B, Graham BS, Kanekiyo M, et al. Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus. Immunity. PMID 31563464 DOI: 10.1016/J.Immuni.2019.09.001 |
0.442 |
|
| 2019 |
Wang N, Rosen O, Wang L, Turner HL, Stevens LJ, Corbett KS, Bowman CA, Pallesen J, Shi W, Zhang Y, Leung K, Kirchdoerfer RN, Becker MM, Denison MR, Chappell JD, ... ... Graham BS, et al. Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD. Cell Reports. 28: 3395-3405.e6. PMID 31553909 DOI: 10.1016/J.Celrep.2019.08.052 |
0.344 |
|
| 2019 |
Ruckwardt TJ, Morabito KM, Graham BS. Immunological Lessons from Respiratory Syncytial Virus Vaccine Development. Immunity. 51: 429-442. PMID 31533056 DOI: 10.1016/j.immuni.2019.08.007 |
0.376 |
|
| 2019 |
Carter C, Houser KV, Yamshchikov GV, Bellamy AR, May J, Enama ME, Sarwar U, Larkin B, Bailer RT, Koup R, Chen GL, Patel SM, Winokur P, Belshe R, Dekker CL, ... Graham BS, et al. Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial. Plos One. 14: e0222178. PMID 31532789 DOI: 10.1371/Journal.Pone.0222178 |
0.422 |
|
| 2019 |
Rudicell RS, Garinot M, Kanekiyo M, Kamp HD, Swanson K, Chou TH, Dai S, Bedel O, Simard D, Gillespie RA, Yang K, Reardon M, Avila LZ, Besev M, Dhal PK, ... ... Graham BS, et al. Comparison of adjuvants to optimize influenza neutralizing antibody responses. Vaccine. PMID 31493950 DOI: 10.1016/J.Vaccine.2019.08.030 |
0.42 |
|
| 2019 |
Gaudinski MR, Houser KV, Doria-Rose NA, Chen GL, Rothwell RSS, Berkowitz N, Costner P, Holman LA, Gordon IJ, Hendel CS, Kaltovich F, Conan-Cibotti M, Gomez Lorenzo M, Carter C, Sitar S, ... ... Graham BS, et al. Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial. The Lancet. Hiv. PMID 31473167 DOI: 10.1016/S2352-3018(19)30181-X |
0.333 |
|
| 2019 |
Crank MC, Ruckwardt TJ, Chen M, Morabito KM, Phung E, Costner PJ, Holman LA, Hickman SP, Berkowitz NM, Gordon IJ, Yamshchikov GV, Gaudinski MR, Kumar A, Chang LA, Moin SM, ... ... Graham BS, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science (New York, N.Y.). 365: 505-509. PMID 31371616 DOI: 10.1126/science.aav9033 |
0.348 |
|
| 2019 |
Andrews SF, Chambers MJ, Schramm CA, Plyler J, Raab JE, Kanekiyo M, Gillespie RA, Ransier A, Darko S, Hu J, Chen X, Yassine HM, Boyington JC, Crank MC, Chen GL, ... ... Graham BS, et al. Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin. Immunity. PMID 31350180 DOI: 10.1016/J.Immuni.2019.06.024 |
0.374 |
|
| 2019 |
Jagger BW, Dowd KA, Chen RE, Desai P, Foreman B, Burgomaster KE, Himansu S, Kong WP, Graham BS, Pierson TC, Diamond MS. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice. The Journal of Infectious Diseases. PMID 31260518 DOI: 10.1093/Infdis/Jiz338 |
0.469 |
|
| 2019 |
Lee Y, Ko EJ, Kim KH, Lee YT, Hwang HS, Kwon YM, Graham BS, Kang SM. A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus. Virology. 534: 1-13. PMID 31163351 DOI: 10.1016/J.Virol.2019.05.010 |
0.49 |
|
| 2019 |
Graham BS. Immunological goals for respiratory syncytial virus vaccine development. Current Opinion in Immunology. 59: 57-64. PMID 31029910 DOI: 10.1016/J.Coi.2019.03.005 |
0.468 |
|
| 2019 |
Schepp RM, de Haan CAM, Wilkins D, Layman H, Graham BS, Esser MT, Berbers GAM. Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins. Msphere. 4. PMID 31019002 DOI: 10.1128/mSphere.00236-19 |
0.354 |
|
| 2019 |
Crowell TA, Colby DJ, Pinyakorn S, Sacdalan C, Pagliuzza A, Intasan J, Benjapornpong K, Tangnaree K, Chomchey N, Kroon E, de Souza MS, Tovanabutra S, Rolland M, Eller MA, Paquin-Proulx D, ... ... Graham BS, et al. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet. Hiv. PMID 31000477 DOI: 10.1016/S2352-3018(19)30053-0 |
0.353 |
|
| 2019 |
Al Kahlout RA, Nasrallah GK, Farag EA, Wang L, Lattwein E, Müller MA, El Zowalaty ME, Al Romaihi HE, Graham BS, Al Thani AA, Yassine HM. Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar. Journal of Immunology Research. 2019: 1386740. PMID 30906787 DOI: 10.1155/2019/1386740 |
0.31 |
|
| 2019 |
Adney DR, Wang L, van Doremalen N, Shi W, Zhang Y, Kong WP, Miller MR, Bushmaker T, Scott D, de Wit E, Modjarrad K, Petrovsky N, Graham BS, Bowen RA, Munster VJ. Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas. Viruses. 11. PMID 30832356 DOI: 10.3390/V11030212 |
0.473 |
|
| 2019 |
Corbett KS, Moin SM, Yassine HM, Cagigi A, Kanekiyo M, Boyoglu-Barnum S, Myers SI, Tsybovsky Y, Wheatley AK, Schramm CA, Gillespie RA, Shi W, Wang L, Zhang Y, Andrews SF, ... ... Graham BS, et al. Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages. Mbio. 10. PMID 30808695 DOI: 10.1128/Mbio.02810-18 |
0.451 |
|
| 2019 |
Sesterhenn F, Galloux M, Vollers SS, Csepregi L, Yang C, Descamps D, Bonet J, Friedensohn S, Gainza P, Corthésy P, Chen M, Rosset S, Rameix-Welti MA, Éléouët JF, Reddy ST, ... Graham BS, et al. Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen. Plos Biology. 17: e3000164. PMID 30789898 DOI: 10.1371/journal.pbio.3000164 |
0.359 |
|
| 2019 |
Kanekiyo M, Joyce MG, Gillespie RA, Gallagher JR, Andrews SF, Yassine HM, Wheatley AK, Fisher BE, Ambrozak DR, Creanga A, Leung K, Yang ES, Boyoglu-Barnum S, Georgiev IS, Tsybovsky Y, ... ... Graham BS, et al. Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. Nature Immunology. PMID 30742080 DOI: 10.1038/S41590-018-0305-X |
0.454 |
|
| 2019 |
Crank MC, Mascola JR, Graham BS. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine. The Journal of Infectious Diseases. PMID 30715413 DOI: 10.1093/Infdis/Jiz043 |
0.406 |
|
| 2019 |
Graham BS, Gilman MSA, McLellan JS. Structure-Based Vaccine Antigen Design. Annual Review of Medicine. 70: 91-104. PMID 30691364 DOI: 10.1146/Annurev-Med-121217-094234 |
0.453 |
|
| 2019 |
Gaudinski MR, Coates EE, Novik L, Widge A, Houser KV, Burch E, Holman LA, Gordon IJ, Chen GL, Carter C, Nason M, Sitar S, Yamshchikov G, Berkowitz N, Andrews C, ... ... Graham BS, et al. Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study. Lancet (London, England). PMID 30686586 DOI: 10.1016/S0140-6736(19)30036-4 |
0.37 |
|
| 2019 |
Çuburu N, Kim R, Guittard GC, Thompson CD, Day PM, Hamm DE, Pang YS, Graham BS, Lowy DR, Schiller JT. A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8 Memory T Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 30635393 DOI: 10.4049/Jimmunol.1800219 |
0.344 |
|
| 2019 |
Jagger BW, Dowd KA, Chen R, Desai P, Himansu S, Graham BS, Pierson TC, Diamond MS. 2904. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice Open Forum Infectious Diseases. 6: S84-S84. DOI: 10.1093/Ofid/Ofz359.182 |
0.482 |
|
| 2018 |
Yamamoto T, Masuta Y, Momota M, Kanekiyo M, Kanuma T, Takahama S, Moriishi E, Yasutomi Y, Saito T, Graham BS, Takahashi Y, Ishii KJ. A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection. International Immunology. PMID 30535055 DOI: 10.1093/Intimm/Dxy069 |
0.469 |
|
| 2018 |
Rosen O, Chan LL, Abiona O, Gough P, Wang L, Shi W, Zhang Y, Wang N, Kong WP, McLellan JS, Graham BS, Corbett KS. A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry. Journal of Virological Methods. PMID 30468747 DOI: 10.1016/J.Jviromet.2018.11.009 |
0.358 |
|
| 2018 |
Kleine-Weber H, Elzayat MT, Wang L, Graham BS, Müller MA, Drosten C, Pöhlmann S, Hoffmann M. Mutations in the spike protein of MERS-CoV transmitted in Korea increase resistance towards antibody-mediated neutralization. Journal of Virology. PMID 30404801 DOI: 10.1128/Jvi.01381-18 |
0.379 |
|
| 2018 |
Zheng Q, Zhu R, Xu L, He M, Yan X, Liu D, Yin Z, Wu Y, Li Y, Yang L, Hou W, Li S, Li Z, Chen Z, Li Z, ... ... Graham BS, et al. Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization. Nature Microbiology. PMID 30397341 DOI: 10.1038/s41564-018-0275-7 |
0.38 |
|
| 2018 |
Houser KV, Yamshchikov GV, Bellamy AR, May J, Enama ME, Sarwar U, Larkin B, Bailer RT, Koup R, Paskel M, Subbarao K, Anderson E, Bernstein DI, Creech B, Keyserling H, ... ... Graham BS, et al. DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial. Plos One. 13: e0206837. PMID 30388160 DOI: 10.1371/Journal.Pone.0206837 |
0.414 |
|
| 2018 |
Park S, Lee Y, Kwon YM, Lee YT, Kim KH, Ko EJ, Jung JH, Song M, Graham B, Prausnitz MR, Kang SM. Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge. Plos One. 13: e0205071. PMID 30365561 DOI: 10.1371/Journal.Pone.0205071 |
0.46 |
|
| 2018 |
Ke Z, Dillard RS, Chirkova T, Leon F, Stobart CC, Hampton CM, Strauss JD, Rajan D, Rostad CA, Taylor JV, Yi H, Shah R, Jin M, Hartert TV, Peebles RS, ... Graham BS, et al. The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography. Viruses. 10. PMID 30127286 DOI: 10.3390/V10080446 |
0.41 |
|
| 2018 |
Mazur NI, Horsley N, Englund JA, Nederend M, Magaret A, Kumar A, Jacobino SR, Xander H, Khatry SK, LeClerq SC, Steinhoff MC, Tielsch JM, Katz J, Graham BS, Bont LJ, et al. Breast milk prefusion F IgG as a correlate of protection against respiratory syncytial virus acute respiratory illness. The Journal of Infectious Diseases. PMID 30107412 DOI: 10.1093/Infdis/Jiy477 |
0.361 |
|
| 2018 |
Mazur NI, Higgins D, Nunes MC, Melero JA, Langedijk AC, Horsley N, Buchholz UJ, Openshaw PJ, McLellan JS, Englund JA, Mejias A, Karron RA, Simões EA, Knezevic I, Ramilo O, ... ... Graham BS, et al. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. The Lancet. Infectious Diseases. PMID 29914800 DOI: 10.1016/S1473-3099(18)30292-5 |
0.448 |
|
| 2018 |
Yassine HM, McTamney PM, Boyington JC, Ruckwardt TJ, Crank MC, Smatti MK, Ledgerwood JE, Graham BS. Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera. Scientific Reports. 8: 8628. PMID 29872070 DOI: 10.1038/S41598-018-26538-7 |
0.364 |
|
| 2018 |
Graham BS, Mascola JR, Fauci AS. Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases. Jama. PMID 29566112 DOI: 10.1001/Jama.2018.0345 |
0.386 |
|
| 2018 |
Wang L, Shi W, Chappell JD, Joyce MG, Zhang Y, Kanekiyo M, Becker MM, van Doremalen N, Fischer R, Wang N, Corbett KS, Choe M, Mason RD, Van Galen JG, Zhou T, ... ... Graham BS, et al. Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape. Journal of Virology. PMID 29514901 DOI: 10.1128/JVI.02002-17 |
0.458 |
|
| 2018 |
Erbelding EJ, Post D, Stemmy E, Roberts PC, Augustine AD, Ferguson S, Paules CI, Graham BS, Fauci AS. A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases. The Journal of Infectious Diseases. PMID 29506129 DOI: 10.1093/Infdis/Jiy103 |
0.401 |
|
| 2018 |
Georgiev IS, Joyce MG, Chen RE, Leung K, McKee K, Druz A, Van Galen JG, Kanekiyo M, Tsybovsky Y, Yang ES, Yang Y, Acharya P, Pancera M, Thomas PV, Wanninger T, ... ... Graham BS, et al. Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens. Acs Infectious Diseases. PMID 29451984 DOI: 10.1021/Acsinfecdis.7B00192 |
0.342 |
|
| 2018 |
Goodwin E, Gilman MSA, Wrapp D, Chen M, Ngwuta JO, Moin SM, Bai P, Sivasubramanian A, Connor RI, Wright PF, Graham BS, McLellan JS, Walker LM. Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation. Immunity. PMID 29396163 DOI: 10.1016/J.Immuni.2018.01.005 |
0.447 |
|
| 2018 |
Vekemans J, Moorthy V, Giersing B, Friede M, Hombach J, Arora N, Modjarrad K, Smith PG, Karron R, Graham B, Kaslow D. Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics. Vaccine. PMID 29395536 DOI: 10.1016/J.Vaccine.2017.09.092 |
0.382 |
|
| 2018 |
Gaudinski MR, Coates EE, Houser KV, Chen GL, Yamshchikov G, Saunders JG, Holman LA, Gordon I, Plummer S, Hendel CS, Conan-Cibotti M, Lorenzo MG, Sitar S, Carlton K, Laurencot C, ... ... Graham BS, et al. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. Plos Medicine. 15: e1002493. PMID 29364886 DOI: 10.1371/Journal.Pmed.1002493 |
0.317 |
|
| 2018 |
Fong Y, Shen X, Ashley VC, Deal A, Seaton KE, Yu C, Grant SP, Ferrari G, deCamp AC, Bailer RT, Koup RA, Montefiori D, Haynes BF, Sarzotti-Kelsoe M, Graham BS, et al. Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505. The Journal of Infectious Diseases. PMID 29325070 DOI: 10.1093/Infdis/Jiy008 |
0.439 |
|
| 2018 |
Wang B, DeKosky BJ, Timm MR, Lee J, Normandin E, Misasi J, Kong R, McDaniel JR, Delidakis G, Leigh KE, Niezold T, Choi CW, Viox EG, Fahad A, Cagigi A, ... ... Graham BS, et al. Functional interrogation and mining of natively paired human VH:VL antibody repertoires. Nature Biotechnology. PMID 29309060 DOI: 10.1038/Nbt.4052 |
0.364 |
|
| 2018 |
Goo L, DeMaso CR, Pelc RS, Ledgerwood JE, Graham BS, Kuhn RJ, Pierson TC. The Zika virus envelope protein glycan loop regulates virion antigenicity. Virology. 515: 191-202. PMID 29304471 DOI: 10.1016/J.Virol.2017.12.032 |
0.363 |
|
| 2018 |
Graham BS, Sullivan NJ. Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic. Nature Immunology. 19: 20-28. PMID 29199281 DOI: 10.1038/S41590-017-0007-9 |
0.351 |
|
| 2017 |
Voronin Y, Jani I, Graham BS, Cunningham CK, Mofenson LM, Musoke PM, Permar SR, Scarlatti G. Recent progress in immune-based interventions to prevent HIV-1 transmission to children. Journal of the International Aids Society. 20. PMID 29282882 DOI: 10.1002/Jia2.25038 |
0.4 |
|
| 2017 |
Morabito KM, Graham BS. Zika Virus Vaccine Development. The Journal of Infectious Diseases. 216: S957-S963. PMID 29267918 DOI: 10.1093/infdis/jix464 |
0.343 |
|
| 2017 |
DeZure AD, Coates EE, Hu Z, Yamshchikov GV, Zephir KL, Enama ME, Plummer SH, Gordon IJ, Kaltovich F, Andrews S, McDermott A, Crank MC, Koup RA, Schwartz RM, Bailer RT, ... ... Graham BS, et al. An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial. Npj Vaccines. 2: 15. PMID 29263871 DOI: 10.1038/s41541-017-0016-6 |
0.31 |
|
| 2017 |
Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, ... ... Graham BS, et al. Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials. Statistical Communications in Infectious Diseases. 9. PMID 29218117 DOI: 10.1515/Scid-2016-0001 |
0.342 |
|
| 2017 |
Gaudinski MR, Houser KV, Morabito KM, Hu Z, Yamshchikov G, Rothwell RS, Berkowitz N, Mendoza F, Saunders JG, Novik L, Hendel CS, Holman LA, Gordon IJ, Cox JH, Edupuganti S, ... ... Graham BS, et al. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials. Lancet (London, England). PMID 29217376 DOI: 10.1016/S0140-6736(17)33105-7 |
0.374 |
|
| 2017 |
Tian D, Battles MB, Moin SM, Chen M, Modjarrad K, Kumar A, Kanekiyo M, Graepel KW, Taher NM, Hotard AL, Moore ML, Zhao M, Zheng ZZ, Xia NS, McLellan JS, ... Graham BS, et al. Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein. Nature Communications. 8: 1877. PMID 29187732 DOI: 10.1038/S41467-017-01858-W |
0.439 |
|
| 2017 |
Rossey I, Gilman MSA, Kabeche SC, Sedeyn K, Wrapp D, Kanekiyo M, Chen M, Mas V, Spitaels J, Melero JA, Graham BS, Schepens B, McLellan JS, Saelens X. Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nature Communications. 8: 16165. PMID 29184149 DOI: 10.1038/Ncomms16165 |
0.362 |
|
| 2017 |
deCamp AC, Rolland M, Edlefsen PT, Sanders-Buell E, Hall B, Magaret CA, Fiore-Gartland AJ, Juraska M, Carpp LN, Karuna ST, Bose M, LePore S, Miller S, O'Sullivan A, Poltavee K, ... ... Graham BS, et al. Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120. Plos One. 12: e0185959. PMID 29149197 DOI: 10.1371/Journal.Pone.0185959 |
0.437 |
|
| 2017 |
Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, ... ... Graham BS, et al. Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial. Plos Medicine. 14: e1002435. PMID 29136037 DOI: 10.1371/Journal.Pmed.1002435 |
0.348 |
|
| 2017 |
Sastry M, Zhang B, Chen M, Joyce MG, Kong WP, Chuang GY, Ko K, Kumar A, Silacci C, Thom M, Salazar AM, Corti D, Lanzavecchia A, Taylor G, Mascola JR, ... Graham BS, et al. Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus. Plos One. 12: e0186854. PMID 29073183 DOI: 10.1371/Journal.Pone.0186854 |
0.401 |
|
| 2017 |
Grifoni A, Pham J, Sidney J, O'Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR, de-Oliveira-Pinto LM, de Azeredo EL, ... ... Graham BS, et al. Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans. Journal of Virology. PMID 28978707 DOI: 10.1128/Jvi.01469-17 |
0.434 |
|
| 2017 |
Shan C, Muruato AE, Jagger BW, Richner J, Nunes BTD, Medeiros DBA, Xie X, Nunes JGC, Morabito KM, Kong WP, Pierson TC, Barrett AD, Weaver SC, Rossi SL, Vasconcelos PFC, ... Graham BS, et al. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nature Communications. 8: 676. PMID 28939807 DOI: 10.1038/S41467-017-00737-8 |
0.385 |
|
| 2017 |
Liu X, Liang B, Ngwuta J, Liu X, Surman S, Lingemann M, Kwong PD, Graham BS, Collins PL, Munir S. Attenuated human parainfluenza virus type 1 (HPIV1) expressing the respiratory syncytial virus (RSV) fusion F glycoprotein from an added gene: effects of pre-fusion stabilization and packaging of RSV F. Journal of Virology. PMID 28835504 DOI: 10.1128/Jvi.01101-17 |
0.403 |
|
| 2017 |
Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, Cottrell CA, Becker MM, Wang L, Shi W, Kong WP, Andres EL, Kettenbach AN, Denison MR, Chappell JD, ... Graham BS, et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proceedings of the National Academy of Sciences of the United States of America. PMID 28807998 DOI: 10.1073/Pnas.1707304114 |
0.366 |
|
| 2017 |
Han Q, Williams WB, Saunders KO, Seaton KE, Wiehe KJ, Vandergrift N, Von Holle T, Trama AM, Parks RJ, Luo K, Gurley TC, Kepler TB, Marshall DJ, Montefiori DC, Sutherland LL, ... ... Graham BS, et al. HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques. Journal of Virology. PMID 28794027 DOI: 10.1128/Jvi.00923-17 |
0.441 |
|
| 2017 |
Andrews SF, Joyce MG, Chambers MJ, Gillespie RA, Kanekiyo M, Leung K, Yang ES, Tsybovsky Y, Wheatley AK, Crank MC, Boyington JC, Prabhakaran MS, Narpala SR, Chen X, Bailer RT, ... ... Graham BS, et al. Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans. Science Immunology. 2. PMID 28783708 DOI: 10.1126/Sciimmunol.Aan2676 |
0.398 |
|
| 2017 |
Andrews SF, Graham BS, Mascola JR, McDermott AB. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem. Cold Spring Harbor Perspectives in Biology. PMID 28663207 DOI: 10.1101/Cshperspect.A029413 |
0.448 |
|
| 2017 |
Liang B, Ngwuta JO, Surman S, Kabatova B, Liu X, Lingemann M, Liu X, Yang L, Herbert R, Swerczek J, Chen M, Moin SM, Kumar A, McLellan JS, Kwong PD, ... Graham BS, et al. Improved prefusion stability, optimized codon-usage, and augmented virion packaging enhance the immunogenicity of respiratory syncytial virus (RSV) fusion protein in a vectored vaccine candidate. Journal of Virology. PMID 28539444 DOI: 10.1128/Jvi.00189-17 |
0.381 |
|
| 2017 |
Zhao M, Zheng ZZ, Chen M, Modjarrad K, Zhang W, Zhan LT, Cao JL, Sun YP, McLellan JS, Graham BS, Xia NS. Discovery of a Prefusion RSV F-Specific Monoclonal Antibody that Provides Greater in vivo Protection than the Murine Precursor of Palivizumab. Journal of Virology. PMID 28539438 DOI: 10.1128/Jvi.00176-17 |
0.388 |
|
| 2017 |
Graham BS. Vaccine development for respiratory syncytial virus. Current Opinion in Virology. 23: 107-112. PMID 28525878 DOI: 10.1016/J.Coviro.2017.03.012 |
0.512 |
|
| 2017 |
Leemans A, De Schryver M, Van der Gucht W, Heykers A, Pintelon I, Hotard AL, Moore ML, Melero JA, McLellan JS, Graham BS, Broadbent L, Power UF, Caljon G, Cos P, Maes L, et al. Antibody-induced internalization of the human respiratory syncytial virus fusion protein. Journal of Virology. PMID 28468888 DOI: 10.1128/Jvi.00184-17 |
0.468 |
|
| 2017 |
Coates EE, Costner PJ, Nason MC, Herrin DM, Conant S, Herscovitch P, Sarwar UN, Holman L, Mitchell J, Yamshchikov G, Koup RA, Graham BS, Millo CM, Ledgerwood JE. Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses. Clinical Nuclear Medicine. PMID 28288041 DOI: 10.1097/Rlu.0000000000001603 |
0.352 |
|
| 2017 |
Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, DeZure A, Enama ME, James ER, Billingsley PF, Gunasekera A, Manoj A, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, ... ... Graham BS, et al. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 28223498 DOI: 10.1073/Pnas.1615324114 |
0.417 |
|
| 2017 |
Janes HE, Cohen KW, Frahm N, De Rosa SC, Sanchez B, Hural J, Magaret CA, Karuna S, Bentley C, Gottardo R, Finak G, Grove D, Shen M, Graham BS, Koup RA, et al. Higher T cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial. The Journal of Infectious Diseases. PMID 28199679 DOI: 10.1093/Infdis/Jix086 |
0.445 |
|
| 2017 |
Rossey I, Gilman MS, Kabeche SC, Sedeyn K, Wrapp D, Kanekiyo M, Chen M, Mas V, Spitaels J, Melero JA, Graham BS, Schepens B, McLellan JS, Saelens X. Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nature Communications. 8: 14158. PMID 28194013 DOI: 10.1038/Ncomms14158 |
0.41 |
|
| 2017 |
Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, Wagner W, Granados A, Greenhouse J, Walker M, Willis E, ... ... Graham BS, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. PMID 28151488 DOI: 10.1038/Nature21428 |
0.444 |
|
| 2016 |
Schwarz B, Morabito KM, Ruckwardt TJ, Patterson DP, Avera J, Miettinen HM, Graham BS, Douglas T. Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses. Acs Biomaterials Science & Engineering. 2: 2324-2332. PMID 29367948 DOI: 10.1021/Acsbiomaterials.6B00532 |
0.322 |
|
| 2016 |
Gilman MS, Castellanos CA, Chen M, Ngwuta JO, Goodwin E, Moin SM, Mas V, Melero JA, Wright PF, Graham BS, McLellan JS, Walker LM. Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors. Science Immunology. 1. PMID 28111638 DOI: 10.1126/Sciimmunol.Aaj1879 |
0.449 |
|
| 2016 |
Stobart CC, Rostad CA, Ke Z, Dillard RS, Hampton CM, Strauss JD, Yi H, Hotard AL, Meng J, Pickles RJ, Sakamoto K, Lee S, Currier MG, Moin SM, Graham BS, et al. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation. Nature Communications. 7: 13916. PMID 28000669 DOI: 10.1038/Ncomms13916 |
0.433 |
|
| 2016 |
Bar KJ, Sneller MC, Harrison LJ, Justement JS, Overton ET, Petrone ME, Salantes DB, Seamon CA, Scheinfeld B, Kwan RW, Learn GH, Proschan MA, Kreider EF, Blazkova J, Bardsley M, ... ... Graham BS, et al. Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. The New England Journal of Medicine. 375: 2037-2050. PMID 27959728 DOI: 10.1056/Nejmoa1608243 |
0.395 |
|
| 2016 |
Graham BS, Repik PM, Yactayo S. Chikungunya in the Americas: Recommendations and Conclusions. The Journal of Infectious Diseases. 214: S510-S513. PMID 27920183 DOI: 10.1093/Infdis/Jiw370 |
0.392 |
|
| 2016 |
DeZure AD, Berkowitz NM, Graham BS, Ledgerwood JE. Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus. The Journal of Infectious Diseases. 214: S497-S499. PMID 27920180 DOI: 10.1093/Infdis/Jiw352 |
0.465 |
|
| 2016 |
Crank MC, Wilson EM, Novik L, Enama ME, Hendel CS, Gu W, Nason MC, Bailer RT, Nabel GJ, McDermott AB, Mascola JR, Koup RA, Ledgerwood JE, Graham BS. Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012). Plos One. 11: e0166393. PMID 27846256 DOI: 10.1371/Journal.Pone.0166393 |
0.415 |
|
| 2016 |
Gilchuk I, Gilchuk P, Sapparapu G, Lampley R, Singh V, Kose N, Blum DL, Hughes LJ, Satheshkumar PS, Townsend MB, Kondas AV, Reed Z, Weiner Z, Olson VA, Hammarlund E, ... ... Graham BS, et al. Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections. Cell. 167: 684-694.e9. PMID 27768891 DOI: 10.1016/J.Cell.2016.09.049 |
0.435 |
|
| 2016 |
Dowd KA, Ko SY, Morabito KM, Yang ES, Pelc RS, DeMaso CR, Castilho LR, Abbink P, Boyd M, Nityanandam R, Gordon DN, Gallagher JR, Chen X, Todd JP, Tsybovsky Y, ... ... Graham BS, et al. Rapid development of a DNA vaccine for Zika virus. Science (New York, N.Y.). PMID 27708058 DOI: 10.1126/Science.Aai9137 |
0.365 |
|
| 2016 |
Pierson TC, Graham BS. Zika Virus: Immunity and Vaccine Development. Cell. PMID 27693357 DOI: 10.1016/J.Cell.2016.09.020 |
0.459 |
|
| 2016 |
Killikelly AM, Kanekiyo M, Graham BS. Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus. Scientific Reports. 6: 34108. PMID 27682426 DOI: 10.1038/Srep34108 |
0.411 |
|
| 2016 |
Goo L, Dowd KA, Lin TY, Mascola JR, Graham BS, Ledgerwood JE, Pierson TC. A virus-like particle vaccine elicits broad neutralizing antibody responses in humans to all Chikungunya virus genotypes. The Journal of Infectious Diseases. PMID 27655868 DOI: 10.1093/Infdis/Jiw431 |
0.45 |
|
| 2016 |
Liang B, Ngwuta JO, Herbert R, Swerczek J, Dorward DW, Amaro-Carambot E, Mackow N, Kabatova B, Lingemann M, Surman S, Yang L, Chen M, Moin SM, Kumar A, McLellan JS, ... ... Graham BS, et al. Packaging and prefusion stabilization separately and additively increase the quantity and quality of RSV-neutralizing antibodies induced by respiratory syncytial virus (RSV) fusion protein expressed by a parainfluenza vector. Journal of Virology. PMID 27581977 DOI: 10.1128/Jvi.01196-16 |
0.413 |
|
| 2016 |
Roberts JN, Graham BS, Karron RA, Munoz FM, Falsey AR, Anderson LJ, Marshall V, Kim S, Beeler JA. Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop. Vaccine. PMID 27566900 DOI: 10.1016/J.Vaccine.2016.07.057 |
0.423 |
|
| 2016 |
Dowd KA, DeMaso CR, Pelc RS, Speer SD, Smith AR, Goo L, Platt DJ, Mascola JR, Graham BS, Mulligan MJ, Diamond MS, Ledgerwood JE, Pierson TC. Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. Cell Reports. PMID 27481466 DOI: 10.1016/J.Celrep.2016.07.049 |
0.438 |
|
| 2016 |
Joyce MG, Zhang B, Ou L, Chen M, Chuang GY, Druz A, Kong WP, Lai YT, Rundlet EJ, Tsybovsky Y, Yang Y, Georgiev IS, Guttman M, Lees CR, Pancera M, ... ... Graham BS, et al. Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV. Nature Structural & Molecular Biology. PMID 27478931 DOI: 10.1038/Nsmb.3267 |
0.434 |
|
| 2016 |
Boyington JC, Joyce MG, Sastry M, Stewart-Jones GB, Chen M, Kong WP, Ngwuta JO, Thomas PV, Tsybovsky Y, Yang Y, Zhang B, Chen L, Druz A, Georgiev IS, Ko K, ... ... Graham BS, et al. Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus. Plos One. 11: e0159709. PMID 27463224 DOI: 10.1371/Journal.Pone.0159709 |
0.418 |
|
| 2016 |
Joyce MG, Wheatley AK, Thomas PV, Chuang GY, Soto C, Bailer RT, Druz A, Georgiev IS, Gillespie RA, Kanekiyo M, Kong WP, Leung K, Narpala SN, Prabhakaran MS, Yang ES, ... ... Graham BS, et al. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses. Cell. PMID 27453470 DOI: 10.1016/J.Cell.2016.06.043 |
0.435 |
|
| 2016 |
Jacobino SR, Nederend M, Hennus M, Houben ML, Ngwuta JO, Viveen M, Coenjaerts FE, Hack CE, van Neerven RJ, Graham BS, Bont L, Leusen JH. Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection. The Journal of Allergy and Clinical Immunology. PMID 27448445 DOI: 10.1016/J.Jaci.2016.06.001 |
0.427 |
|
| 2016 |
Rostad CA, Stobart CC, Gilbert BE, Pickles RJ, Hotard AL, Meng J, Blanco JC, Moin SM, Graham BS, Piedra PA, Moore ML. A recombinant respiratory syncytial virus vaccine candidate attenuated by a low-fusion F protein is immunogenic and protective against challenge in cotton rats. Journal of Virology. PMID 27279612 DOI: 10.1128/Jvi.00012-16 |
0.459 |
|
| 2016 |
Ishizuka AS, Lyke KE, DeZure A, Berry AA, Richie TL, Mendoza FH, Enama ME, Gordon IJ, Chang LJ, Sarwar UN, Zephir KL, Holman LA, James ER, Billingsley PF, Gunasekera A, ... ... Graham BS, et al. Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nature Medicine. 22: 692. PMID 27270781 DOI: 10.1038/Nm0616-692C |
0.311 |
|
| 2016 |
Graham BS. Vaccines against respiratory syncytial virus: The time has finally come. Vaccine. PMID 27182820 DOI: 10.1016/J.Vaccine.2016.04.083 |
0.47 |
|
| 2016 |
Ishizuka AS, Lyke KE, DeZure A, Berry AA, Richie TL, Mendoza FH, Enama ME, Gordon IJ, Chang LJ, Sarwar UN, Zephir KL, Holman LA, James ER, Billingsley PF, Gunasekera A, ... ... Graham BS, et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nature Medicine. PMID 27158907 DOI: 10.1038/Nm.4110 |
0.424 |
|
| 2016 |
Hessell AJ, Jaworski JP, Epson E, Matsuda K, Pandey S, Kahl C, Reed J, Sutton WF, Hammond KB, Cheever TA, Barnette PT, Legasse AW, Planer S, Stanton JJ, Pegu A, ... ... Graham BS, et al. Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques. Nature Medicine. PMID 26998834 DOI: 10.1038/Nm.4063 |
0.413 |
|
| 2016 |
Ruckwardt TJ, Morabito KM, Graham BS. Determinants of early life immune responses to RSV infection. Current Opinion in Virology. 16: 151-157. PMID 26986236 DOI: 10.1016/j.coviro.2016.01.003 |
0.32 |
|
| 2016 |
Kirchdoerfer RN, Cottrell CA, Wang N, Pallesen J, Yassine HM, Turner HL, Corbett KS, Graham BS, McLellan JS, Ward AB. Pre-fusion structure of a human coronavirus spike protein. Nature. 531: 118-21. PMID 26935699 DOI: 10.1038/Nature17200 |
0.357 |
|
| 2016 |
Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, ... ... Graham BS, et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science (New York, N.Y.). PMID 26917593 DOI: 10.1126/Science.Aad5224 |
0.481 |
|
| 2016 |
Misasi J, Gilman MS, Kanekiyo M, Gui M, Cagigi A, Mulangu S, Corti D, Ledgerwood JE, Lanzavecchia A, Cunningham J, Muyembe-Tamfun JJ, Baxa U, Graham BS, Xiang Y, Sullivan NJ, et al. Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science (New York, N.Y.). PMID 26917592 DOI: 10.1126/Science.Aad6117 |
0.443 |
|
| 2016 |
Morabito KM, Erez N, Graham BS, Ruckwardt TJ. Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus KdM282-90 Epitope Is Transfer Dose-Dependent. Plos One. 11: e0146781. PMID 26752171 DOI: 10.1371/Journal.Pone.0146781 |
0.341 |
|
| 2016 |
Giersing BK, Modjarrad K, Kaslow DC, Moorthy VS, Bavdekar A, Cichutek K, Cravioto A, Fritzell B, Graham BS, Karron R, Lanata CF, Powell M, Shao Y, Smith P. Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015 Vaccine. 34: 2865-2869. DOI: 10.1016/J.Vaccine.2016.02.078 |
0.357 |
|
| 2016 |
DeZure A, Graham BS. Vaccines for Emerging Viral Diseases The Vaccine Book: Second Edition. 543-560. DOI: 10.1016/B978-0-12-802174-3.00028-X |
0.304 |
|
| 2015 |
De Santis O, Audran R, Pothin E, Warpelin-Decrausaz L, Vallotton L, Wuerzner G, Cochet C, Estoppey D, Steiner-Monard V, Lonchampt S, Thierry AC, Mayor C, Bailer RT, Mbaya OT, Zhou Y, ... ... Graham BS, et al. Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study. The Lancet. Infectious Diseases. PMID 26725450 DOI: 10.1016/S1473-3099(15)00486-7 |
0.394 |
|
| 2015 |
Lynch RM, Boritz E, Coates EE, DeZure A, Madden P, Costner P, Enama ME, Plummer S, Holman L, Hendel CS, Gordon I, Casazza J, Conan-Cibotti M, Migueles SA, Tressler R, ... ... Graham BS, et al. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Science Translational Medicine. 7: 319ra206. PMID 26702094 DOI: 10.1126/Scitranslmed.Aad5752 |
0.402 |
|
| 2015 |
Fuchs JD, Bart PA, Frahm N, Morgan C, Gilbert PB, Kochar N, DeRosa SC, Tomaras GD, Wagner TM, Baden LR, Koblin BA, Rouphael NG, Kalams SA, Keefer MC, Goepfert PA, ... ... Graham BS, et al. Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. Journal of Aids & Clinical Research. 6. PMID 26587311 DOI: 10.4172/2155-6113.1000461 |
0.426 |
|
| 2015 |
Tapia MD, Sow SO, Lyke KE, Haidara FC, Diallo F, Doumbia M, Traore A, Coulibaly F, Kodio M, Onwuchekwa U, Sztein MB, Wahid R, Campbell JD, Kieny MP, Moorthy V, ... ... Graham B, et al. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial. The Lancet. Infectious Diseases. PMID 26546548 DOI: 10.1016/S1473-3099(15)00362-X |
0.432 |
|
| 2015 |
Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, ... ... Graham BS, et al. Vaccination with heterologous HIV envelope sequences and heterologous adenovirus vectors increases T cell responses to conserved regions (HVTN 083). The Journal of Infectious Diseases. PMID 26475930 DOI: 10.1093/Infdis/Jiv496 |
0.433 |
|
| 2015 |
Ngwuta JO, Chen M, Modjarrad K, Joyce MG, Kanekiyo M, Kumar A, Yassine HM, Moin SM, Killikelly AM, Chuang GY, Druz A, Georgiev IS, Rundlet EJ, Sastry M, Stewart-Jones GB, ... ... Graham BS, et al. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Science Translational Medicine. 7: 309ra162. PMID 26468324 DOI: 10.1126/Scitranslmed.Aac4241 |
0.344 |
|
| 2015 |
Huang Y, Follmann D, Nason M, Zhang L, Huang Y, Mehrotra DV, Moodie Z, Metch B, Janes H, Keefer MC, Churchyard G, Robb ML, Fast PE, Duerr A, McElrath MJ, ... ... Graham BS, et al. Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials. Plos One. 10: e0136626. PMID 26332672 DOI: 10.1371/Journal.Pone.0136626 |
0.396 |
|
| 2015 |
Ledgerwood JE, Coates EE, Yamshchikov G, Saunders JG, Holman L, Enama ME, DeZure A, Lynch R, Gordon I, Plummer S, Hendel CS, Pegu A, Conan-Cibotti M, Sitar S, Bailer RT, ... ... Graham BS, et al. Safety, Pharmacokinetics, and Neutralization of the Broadly Neutralizing HIV-1 Human Monoclonal Antibody VRC01 in Healthy Adults. Clinical and Experimental Immunology. PMID 26332605 DOI: 10.1111/Cei.12692 |
0.307 |
|
| 2015 |
Yassine HM, Boyington JC, McTamney PM, Wei CJ, Kanekiyo M, Kong WP, Gallagher JR, Wang L, Zhang Y, Joyce MG, Lingwood D, Moin SM, Andersen H, Okuno Y, Rao SS, ... ... Graham BS, et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nature Medicine. PMID 26301691 DOI: 10.1038/Nm.3927 |
0.404 |
|
| 2015 |
Kanekiyo M, Bu W, Joyce MG, Meng G, Whittle JR, Baxa U, Yamamoto T, Narpala S, Todd JP, Rao SS, McDermott AB, Koup RA, Rossmann MG, Mascola JR, Graham BS, et al. Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site. Cell. 162: 1090-100. PMID 26279189 DOI: 10.1016/J.Cell.2015.07.043 |
0.455 |
|
| 2015 |
Ledgerwood JE, Hu Z, Costner P, Yamshchikov G, Enama ME, Plummer S, Hendel CS, Holman L, Larkin B, Gordon I, Bailer RT, Poretz DM, Sarwar U, Kabadi A, Koup R, ... ... Graham BS, et al. Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost. Contemporary Clinical Trials. PMID 26275339 DOI: 10.1016/J.Cct.2015.08.006 |
0.423 |
|
| 2015 |
Williams WB, Liao HX, Moody MA, Kepler TB, Alam SM, Gao F, Wiehe K, Trama AM, Jones K, Zhang R, Song H, Marshall DJ, Whitesides JF, Sawatzki K, Hua A, ... ... Graham BS, et al. HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies. Science (New York, N.Y.). 349: aab1253. PMID 26229114 DOI: 10.1126/Science.Aab1253 |
0.426 |
|
| 2015 |
Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Lees CR, Zhou T, Yassine HM, Kanekiyo M, Yang ZY, Chen X, Becker MM, Freeman M, Vogel L, ... ... Graham BS, et al. Evaluation of candidate vaccine approaches for MERS-CoV. Nature Communications. 6: 7712. PMID 26218507 DOI: 10.1038/Ncomms8712 |
0.445 |
|
| 2015 |
Gilman MS, Moin SM, Mas V, Chen M, Patel NK, Kramer K, Zhu Q, Kabeche SC, Kumar A, Palomo C, Beaumont T, Baxa U, Ulbrandt ND, Melero JA, Graham BS, et al. Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein. Plos Pathogens. 11: e1005035. PMID 26161532 DOI: 10.1371/Journal.Ppat.1005035 |
0.389 |
|
| 2015 |
Liang B, Surman S, Amaro-Carambot E, Kabatova B, Mackow N, Lingemann M, Yang L, McLellan JS, Graham BS, Kwong PD, Schaap-Nutt A, Collins PL, Munir S. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Pre-fusion F Protein Expressed by a Vaccine Candidate. Journal of Virology. PMID 26157122 DOI: 10.1128/Jvi.01373-15 |
0.448 |
|
| 2015 |
Stewart-Jones GB, Thomas PV, Chen M, Druz A, Joyce MG, Kong WP, Sastry M, Soto C, Yang Y, Zhang B, Chen L, Chuang GY, Georgiev IS, McLellan JS, Srivatsan S, ... ... Graham BS, et al. A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus. Plos One. 10: e0128779. PMID 26098893 DOI: 10.1371/Journal.Pone.0128779 |
0.422 |
|
| 2015 |
Wheatley AK, Whittle JR, Lingwood D, Kanekiyo M, Yassine HM, Ma SS, Narpala SR, Prabhakaran MS, Matus-Nicodemos RA, Bailer RT, Nabel GJ, Graham BS, Ledgerwood JE, Koup RA, McDermott AB. H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem. Journal of Immunology (Baltimore, Md. : 1950). 195: 602-10. PMID 26078272 DOI: 10.4049/Jimmunol.1402835 |
0.417 |
|
| 2015 |
Graham BS, Modjarrad K, McLellan JS. Novel antigens for RSV vaccines. Current Opinion in Immunology. 35: 30-8. PMID 26070108 DOI: 10.1016/J.Coi.2015.04.005 |
0.428 |
|
| 2015 |
Ledgerwood JE, Bellamy AR, Belshe R, Bernstein DI, Edupuganti S, Patel SM, Renehan P, Zajdowicz T, Schwartz R, Koup R, Bailer RT, Yamshchikov GV, Enama ME, Sarwar U, Larkin B, ... Graham BS, et al. DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial. Plos One. 10: e0125914. PMID 25950433 DOI: 10.1371/Journal.Pone.0125914 |
0.426 |
|
| 2015 |
Crank MC, Gordon IJ, Yamshchikov GV, Sitar S, Hu Z, Enama ME, Holman LA, Bailer RT, Pearce MB, Koup RA, Mascola JR, Nabel GJ, Tumpey TM, Schwartz RM, Graham BS, et al. Phase 1 study of pandemic H1 DNA vaccine in healthy adults. Plos One. 10: e0123969. PMID 25884189 DOI: 10.1371/Journal.Pone.0123969 |
0.441 |
|
| 2015 |
Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, Muñoz P, Moon JE, Ruck RC, Bennett JW, Twomey PS, Gutiérrez RL, Remich SA, Hack HR, Wisniewski ML, Josleyn MD, ... ... Graham BS, et al. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine - Preliminary Report. The New England Journal of Medicine. PMID 25830322 DOI: 10.1056/Nejmoa1414216 |
0.458 |
|
| 2015 |
Kines RC, Zarnitsyn V, Johnson TR, Pang YY, Corbett KS, Nicewonger JD, Gangopadhyay A, Chen M, Liu J, Prausnitz MR, Schiller JT, Graham BS. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles. Plos One. 10: e0120797. PMID 25785935 DOI: 10.1371/Journal.Pone.0120797 |
0.316 |
|
| 2015 |
Graham BS, Ambrosino DM. History of passive antibody administration for prevention and treatment of infectious diseases. Current Opinion in Hiv and Aids. 10: 129-34. PMID 25760933 DOI: 10.1097/Coh.0000000000000154 |
0.35 |
|
| 2015 |
Rampling T, Ewer K, Bowyer G, Wright D, Imoukhuede EB, Payne R, Hartnell F, Gibani M, Bliss C, Minhinnick A, Wilkie M, Venkatraman N, Poulton I, Lella N, Roberts R, ... ... Graham BS, et al. A Monovalent Chimpanzee Adenovirus Ebola Vaccine - Preliminary Report. The New England Journal of Medicine. PMID 25629663 DOI: 10.1056/Nejmoa1411627 |
0.443 |
|
| 2015 |
Kibuuka H, Berkowitz NM, Millard M, Enama ME, Tindikahwa A, Sekiziyivu AB, Costner P, Sitar S, Glover D, Hu Z, Joshi G, Stanley D, Kunchai M, Eller LA, Bailer RT, ... ... Graham BS, et al. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial. Lancet (London, England). 385: 1545-54. PMID 25540891 DOI: 10.1016/S0140-6736(14)62385-0 |
0.473 |
|
| 2015 |
Sarwar UN, Costner P, Enama ME, Berkowitz N, Hu Z, Hendel CS, Sitar S, Plummer S, Mulangu S, Bailer RT, Koup RA, Mascola JR, Nabel GJ, Sullivan NJ, Graham BS, et al. Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial. The Journal of Infectious Diseases. 211: 549-57. PMID 25225676 DOI: 10.1093/Infdis/Jiu511 |
0.386 |
|
| 2015 |
Sarwar U, Novik L, Enama M, Herrin D, Narpala S, Mcdermott A, Graham BS, Ledgerwood J. Early Innate and Adaptive Immune Responses to Investigational Human Immunodeficiency Virus (HIV)-1 Vaccines (VRC 016 study) Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.621 |
0.442 |
|
| 2015 |
Rampling T, Ewer K, Bowyer G, Wright D, Venkatraman N, Payne R, Nicosia A, Sullivan N, Graham B, Pollard A, Draper S, Ballou R, Lawrie A, Gilbert S, Hill A. Safety and immunogenicity of the heterologous prime-boost ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN (R) FILO in healthy UK adults Journal of Infection. 71: 688-688. DOI: 10.1016/J.Jinf.2015.09.031 |
0.406 |
|
| 2014 |
Herrin DM, Coates EE, Costner PJ, Kemp TJ, Nason MC, Saharia KK, Pan Y, Sarwar UN, Holman L, Yamshchikov G, Koup RA, Pang YY, Seder RA, Schiller JT, Graham BS, et al. Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus. Human Vaccines & Immunotherapeutics. 10: 3446-54. PMID 25483691 DOI: 10.4161/Hv.34408 |
0.399 |
|
| 2014 |
Ledgerwood JE, DeZure AD, Stanley DA, Novik L, Enama ME, Berkowitz NM, Hu Z, Joshi G, Ploquin A, Sitar S, Gordon IJ, Plummer SA, Holman LA, Hendel CS, Yamshchikov G, ... ... Graham BS, et al. Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report. The New England Journal of Medicine. PMID 25426834 DOI: 10.1056/Nejmoa1410863 |
0.394 |
|
| 2014 |
Gordon SN, Doster MN, Kines RC, Keele BF, Brocca-Cofano E, Guan Y, Pegu P, Liyanage NP, Vaccari M, Cuburu N, Buck CB, Ferrari G, Montefiori D, Piatak M, Lifson JD, ... ... Graham BS, et al. Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia. Journal of Immunology (Baltimore, Md. : 1950). 193: 6172-83. PMID 25398324 DOI: 10.4049/Jimmunol.1401504 |
0.411 |
|
| 2014 |
Bart PA, Huang Y, Karuna ST, Chappuis S, Gaillard J, Kochar N, Shen X, Allen MA, Ding S, Hural J, Liao HX, Haynes BF, Graham BS, Gilbert PB, McElrath MJ, et al. HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial. The Journal of Clinical Investigation. 124: 4843-56. PMID 25271627 DOI: 10.1172/Jci75894 |
0.422 |
|
| 2014 |
Sarwar UN, Novik L, Enama ME, Plummer SA, Koup RA, Nason MC, Bailer RT, McDermott AB, Roederer M, Mascola JR, Ledgerwood JE, Graham BS. Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial. Plos One. 9: e106240. PMID 25264782 DOI: 10.1371/Journal.Pone.0106240 |
0.419 |
|
| 2014 |
Rudicell RS, Kwon YD, Ko SY, Pegu A, Louder MK, Georgiev IS, Wu X, Zhu J, Boyington JC, Chen X, Shi W, Yang ZY, Doria-Rose NA, McKee K, O'Dell S, ... ... Graham BS, et al. Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo. Journal of Virology. 88: 12669-82. PMID 25142607 DOI: 10.1128/Jvi.02213-14 |
0.42 |
|
| 2014 |
Chang LJ, Dowd KA, Mendoza FH, Saunders JG, Sitar S, Plummer SH, Yamshchikov G, Sarwar UN, Hu Z, Enama ME, Bailer RT, Koup RA, Schwartz RM, Akahata W, Nabel GJ, ... ... Graham BS, et al. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. Lancet. 384: 2046-52. PMID 25132507 DOI: 10.1016/S0140-6736(14)61185-5 |
0.432 |
|
| 2014 |
Bar-Haim E, Erez N, Malloy AM, Graham BS, Ruckwardt TJ. CD8+ TCR transgenic strains expressing public versus private TCR targeting the respiratory syncytial virus K(d)M2(82-90) epitope demonstrate similar functional profiles. Plos One. 9: e99249. PMID 24897427 DOI: 10.1371/Journal.Pone.0099249 |
0.353 |
|
| 2014 |
Manrique A, Adams E, Barouch DH, Fast P, Graham BS, Kim JH, Kublin JG, McCluskey M, Pantaleo G, Robinson HL, Russell N, Snow W, Johnston MI. The immune space: a concept and template for rationalizing vaccine development. Aids Research and Human Retroviruses. 30: 1017-22. PMID 24857015 DOI: 10.1089/Aid.2014.0040 |
0.413 |
|
| 2014 |
Kiss G, Holl JM, Williams GM, Alonas E, Vanover D, Lifland AW, Gudheti M, Guerrero-Ferreira RC, Nair V, Yi H, Graham BS, Santangelo PJ, Wright ER. Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex. Journal of Virology. 88: 7602-17. PMID 24760890 DOI: 10.1128/Jvi.00256-14 |
0.332 |
|
| 2014 |
Enama ME, Ledgerwood JE, Novik L, Nason MC, Gordon IJ, Holman L, Bailer RT, Roederer M, Koup RA, Mascola JR, Nabel GJ, Graham BS. Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011). Plos One. 9: e91366. PMID 24621858 DOI: 10.1371/Journal.Pone.0091366 |
0.332 |
|
| 2014 |
Graham BS. Protecting the family to protect the child: vaccination strategy guided by RSV transmission dynamics. The Journal of Infectious Diseases. 209: 1679-81. PMID 24523511 DOI: 10.1093/Infdis/Jiu075 |
0.383 |
|
| 2014 |
Liu J, Cao S, Peppers G, Kim SH, Graham BS. Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responses. European Journal of Immunology. 44: 1058-68. PMID 24510524 DOI: 10.1002/Eji.201343766 |
0.372 |
|
| 2014 |
Whittle JR, Wheatley AK, Wu L, Lingwood D, Kanekiyo M, Ma SS, Narpala SR, Yassine HM, Frank GM, Yewdell JW, Ledgerwood JE, Wei CJ, McDermott AB, Graham BS, Koup RA, et al. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. Journal of Virology. 88: 4047-57. PMID 24501410 DOI: 10.1128/Jvi.03422-13 |
0.403 |
|
| 2014 |
Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, ... ... Graham BS, et al. Proof of principle for epitope-focused vaccine design. Nature. 507: 201-6. PMID 24499818 DOI: 10.1038/Nature12966 |
0.483 |
|
| 2014 |
Johnson TR, Rangel D, Graham BS, Brough DE, Gall JG. Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 196-205. PMID 23752342 DOI: 10.1038/Mt.2013.142 |
0.498 |
|
| 2014 |
Billingsley P, Sim BKL, James E, Richie T, Shekalaghe S, Healy S, Sissoko M, Mordmueller B, Ledgerwood J, Graham B, Duffy P, Seder R, Lyke K, Epstein J, Alonso P, et al. Progress with PfSPZ Vaccine, a radiation attenuated Plasmodium falciparum sporozoite vaccine Malaria Journal. 13. DOI: 10.1186/1475-2875-13-S1-O34 |
0.38 |
|
| 2014 |
Malloy A, Ruckwardt T, Morabito K, Graham B. 1354Toll-like Receptor Agonists Alter the CD8+ T Cell Response Hierarchy in Neonates During Respiratory Syncytial Virus Infection Open Forum Infectious Diseases. 1. DOI: 10.1093/Ofid/Ofu052.900 |
0.379 |
|
| 2013 |
Graham BS, Anderson LJ. Challenges and opportunities for respiratory syncytial virus vaccines. Current Topics in Microbiology and Immunology. 372: 391-404. PMID 24362701 DOI: 10.1007/978-3-642-38919-1_20 |
0.46 |
|
| 2013 |
Collins PL, Fearns R, Graham BS. Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Current Topics in Microbiology and Immunology. 372: 3-38. PMID 24362682 DOI: 10.1007/978-3-642-38919-1_1 |
0.436 |
|
| 2013 |
McLellan JS, Chen M, Joyce MG, Sastry M, Stewart-Jones GB, Yang Y, Zhang B, Chen L, Srivatsan S, Zheng A, Zhou T, Graepel KW, Kumar A, Moin S, Boyington JC, ... ... Graham BS, et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science (New York, N.Y.). 342: 592-8. PMID 24179220 DOI: 10.1126/Science.1243283 |
0.418 |
|
| 2013 |
Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, et al. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. The New England Journal of Medicine. 369: 2083-92. PMID 24099601 DOI: 10.1056/Nejmoa1310566 |
0.425 |
|
| 2013 |
Hillyer P, Raviv N, Gold DM, Dougherty D, Liu J, Johnson TR, Graham BS, Rabin RL. Subtypes of type I IFN differentially enhance cytokine expression by suboptimally stimulated CD4(+) T cells. European Journal of Immunology. 43: 3197-208. PMID 24030809 DOI: 10.1002/Eji.201243288 |
0.315 |
|
| 2013 |
Graham BS. Advances in antiviral vaccine development. Immunological Reviews. 255: 230-42. PMID 23947359 DOI: 10.1111/Imr.12098 |
0.442 |
|
| 2013 |
Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, ... ... Graham BS, et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science (New York, N.Y.). 341: 1359-65. PMID 23929949 DOI: 10.1126/Science.1241800 |
0.392 |
|
| 2013 |
Hertz T, Ahmed H, Friedrich DP, Casimiro DR, Self SG, Corey L, McElrath MJ, Buchbinder S, Horton H, Frahm N, Robertson MN, Graham BS, Gilbert P. HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1. Plos Pathogens. 9: e1003404. PMID 23818843 DOI: 10.1371/Journal.Ppat.1003404 |
0.432 |
|
| 2013 |
Ledgerwood JE, Zephir K, Hu Z, Wei CJ, Chang L, Enama ME, Hendel CS, Sitar S, Bailer RT, Koup RA, Mascola JR, Nabel GJ, Graham BS. Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect. The Journal of Infectious Diseases. 208: 418-22. PMID 23633407 DOI: 10.1093/Infdis/Jit180 |
0.405 |
|
| 2013 |
Khurana S, Wu J, Dimitrova M, King LR, Manischewitz J, Graham BS, Ledgerwood JE, Golding H. DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults. The Journal of Infectious Diseases. 208: 413-7. PMID 23633404 DOI: 10.1093/Infdis/Jit178 |
0.421 |
|
| 2013 |
Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine. 31: B209-15. PMID 23598484 DOI: 10.1016/J.Vaccine.2012.11.106 |
0.463 |
|
| 2013 |
Graham BS, Enama ME, Nason MC, Gordon IJ, Peel SA, Ledgerwood JE, Plummer SA, Mascola JR, Bailer RT, Roederer M, Koup RA, Nabel GJ. DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial. Plos One. 8: e59340. PMID 23577062 DOI: 10.1371/Journal.Pone.0059340 |
0.35 |
|
| 2013 |
Casazza JP, Bowman KA, Adzaku S, Smith EC, Enama ME, Bailer RT, Price DA, Gostick E, Gordon IJ, Ambrozak DR, Nason MC, Roederer M, Andrews CA, Maldarelli FM, Wiegand A, ... ... Graham BS, et al. Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire. The Journal of Infectious Diseases. 207: 1829-40. PMID 23482645 DOI: 10.1093/Infdis/Jit098 |
0.469 |
|
| 2013 |
Chang L, Mendoza F, Saunders J, Plummer S, Yamshchikov GV, Ledgerwood JE, Graham BS. VRC 311: Phase I Clinical Trial of a Virus-Like Particle Chikungunya Vaccine in Healthy Adults The Journal of Allergy and Clinical Immunology. 131. DOI: 10.1016/J.Jaci.2012.12.1555 |
0.389 |
|
| 2012 |
Çuburu N, Graham BS, Buck CB, Kines RC, Pang YY, Day PM, Lowy DR, Schiller JT. Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. The Journal of Clinical Investigation. 122: 4606-20. PMID 23143305 DOI: 10.1172/Jci63287 |
0.329 |
|
| 2012 |
Ledgerwood JE, Hu Z, Gordon IJ, Yamshchikov G, Enama ME, Plummer S, Bailer R, Pearce MB, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS. Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans. Clinical and Vaccine Immunology : Cvi. 19: 1792-7. PMID 22956656 DOI: 10.1128/Cvi.05663-11 |
0.42 |
|
| 2012 |
Schmidt C, Smith C, Barin B, Bakhtyari A, Bart PA, Bekker LG, Chomba E, Clumeck N, Ho D, Hoosen A, Jaoko W, Kaleebu P, Karita E, Keefer MC, van Lunzen J, ... ... Graham BS, et al. Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events. Human Vaccines & Immunotherapeutics. 8: 630-8. PMID 22634443 DOI: 10.4161/Hv.19454 |
0.367 |
|
| 2012 |
Gordon SN, Kines RC, Kutsyna G, Ma ZM, Hryniewicz A, Roberts JN, Fenizia C, Hidajat R, Brocca-Cofano E, Cuburu N, Buck CB, Bernardo ML, Robert-Guroff M, Miller CJ, Graham BS, et al. Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA. Journal of Immunology (Baltimore, Md. : 1950). 188: 714-23. PMID 22174446 DOI: 10.4049/Jimmunol.1101404 |
0.408 |
|
| 2012 |
Johnson TR, McLellan JS, Graham BS. Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2. Journal of Virology. 86: 1339-47. PMID 22090124 DOI: 10.1128/Jvi.06096-11 |
0.304 |
|
| 2012 |
Enama M, Jones N, Graham B, Lane H. Update on policy change proposal to end Institutional Biosafety Committee (IBC) review of rDNA vaccine clinical trials Retrovirology. 9: 241. DOI: 10.1186/1742-4690-9-S2-P241 |
0.394 |
|
| 2012 |
Williams W, Jones K, Krambrink A, Grove D, Liu P, Yates N, Moody M, Ferrari G, Pollara J, Moodie Z, Morgan C, Liao H, Montefiori D, Ochsenbauer C, Kappes J, ... ... Graham B, et al. Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-O55 |
0.349 |
|
| 2011 |
Rimoin AW, Graham BS. Whither monkeypox vaccination. Vaccine. 29: D60-4. PMID 22188935 DOI: 10.1016/J.Vaccine.2011.09.004 |
0.383 |
|
| 2011 |
Ruckwardt TJ, Malloy AM, Gostick E, Price DA, Dash P, McClaren JL, Thomas PG, Graham BS. Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice. Plos Pathogens. 7: e1002377. PMID 22144888 DOI: 10.1371/Journal.Ppat.1002377 |
0.383 |
|
| 2011 |
Graham BS. Future opportunities for passive immunity against viral diseases. The Journal of Infectious Diseases. 204: 1648-50. PMID 21998473 DOI: 10.1093/Infdis/Jir628 |
0.481 |
|
| 2011 |
Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, McTamney PM, Pearce MB, Yassine HM, Boyington JC, Bailer R, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, ... Graham BS, et al. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. The Lancet. Infectious Diseases. 11: 916-24. PMID 21975270 DOI: 10.1016/S1473-3099(11)70240-7 |
0.452 |
|
| 2011 |
Baden LR, Blattner WA, Morgan C, Huang Y, Defawe OD, Sobieszczyk ME, Kochar N, Tomaras GD, McElrath MJ, Russell N, Brandariz K, Cardinali M, Graham BS, Barouch DH, Dolin R, et al. Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects. The Journal of Infectious Diseases. 204: 1541-9. PMID 21940420 DOI: 10.1093/Infdis/Jir615 |
0.363 |
|
| 2011 |
Koblin BA, Casapia M, Morgan C, Qin L, Wang ZM, Defawe OD, Baden L, Goepfert P, Tomaras GD, Montefiori DC, McElrath MJ, Saavedra L, Lau CY, Graham BS. Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial. Plos One. 6: e24517. PMID 21931737 DOI: 10.1371/Journal.Pone.0024517 |
0.379 |
|
| 2011 |
Judkowski V, Bunying A, Ge F, Appel JR, Law K, Sharma A, Raja-Gabaglia C, Norori P, Santos RG, Giulianotti MA, Slifka MK, Douek DC, Graham BS, Pinilla C. GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination. Plos One. 6: e24091. PMID 21931646 DOI: 10.1371/Journal.Pone.0024091 |
0.383 |
|
| 2011 |
Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, et al. A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). Plos One. 6: e21225. PMID 21857901 DOI: 10.1371/Journal.Pone.0021225 |
0.338 |
|
| 2011 |
De Rosa SC, Thomas EP, Bui J, Huang Y, deCamp A, Morgan C, Kalams SA, Tomaras GD, Akondy R, Ahmed R, Lau CY, Graham BS, Nabel GJ, McElrath MJ. HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable. Journal of Immunology (Baltimore, Md. : 1950). 187: 3391-401. PMID 21844392 DOI: 10.4049/Jimmunol.1101421 |
0.398 |
|
| 2011 |
Li Y, O'Dell S, Walker LM, Wu X, Guenaga J, Feng Y, Schmidt SD, McKee K, Louder MK, Ledgerwood JE, Graham BS, Haynes BF, Burton DR, Wyatt RT, Mascola JR. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. Journal of Virology. 85: 8954-67. PMID 21715490 DOI: 10.1128/Jvi.00754-11 |
0.345 |
|
| 2011 |
McLellan JS, Yang Y, Graham BS, Kwong PD. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. Journal of Virology. 85: 7788-96. PMID 21613394 DOI: 10.1128/Jvi.00555-11 |
0.354 |
|
| 2011 |
McLellan JS, Correia BE, Chen M, Yang Y, Graham BS, Schief WR, Kwong PD. Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus. Journal of Molecular Biology. 409: 853-66. PMID 21549714 DOI: 10.1016/J.Jmb.2011.04.044 |
0.488 |
|
| 2011 |
Ledgerwood JE, Pierson TC, Hubka SA, Desai N, Rucker S, Gordon IJ, Enama ME, Nelson S, Nason M, Gu W, Bundrant N, Koup RA, Bailer RT, Mascola JR, Nabel GJ, ... Graham BS, et al. A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial. The Journal of Infectious Diseases. 203: 1396-404. PMID 21398392 DOI: 10.1093/Infdis/Jir054 |
0.44 |
|
| 2011 |
Johnson TR, Johnson CN, Corbett KS, Edwards GC, Graham BS. Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus. Plos One. 6: e16458. PMID 21297989 DOI: 10.1371/Journal.Pone.0016458 |
0.46 |
|
| 2011 |
Graham BS. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunological Reviews. 239: 149-66. PMID 21198670 DOI: 10.1111/J.1600-065X.2010.00972.X |
0.519 |
|
| 2011 |
Koup RA, Graham BS, Douek DC. The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors. Nature Reviews. Immunology. 11: 65-70. PMID 21164527 DOI: 10.1038/Nri2890 |
0.404 |
|
| 2011 |
Billam P, Bonaparte KL, Liu J, Ruckwardt TJ, Chen M, Ryder AB, Wang R, Dash P, Thomas PG, Graham BS. T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection. The Journal of Biological Chemistry. 286: 4829-41. PMID 21118816 DOI: 10.1074/Jbc.M110.191437 |
0.358 |
|
| 2010 |
Peiperl L, Morgan C, Moodie Z, Li H, Russell N, Graham BS, Tomaras GD, De Rosa SC, McElrath MJ. Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054). Plos One. 5: e13579. PMID 21048953 DOI: 10.1371/Journal.Pone.0013579 |
0.439 |
|
| 2010 |
Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, Koup RA, Roederer M, Bailer R, Mascola JR, Pau MG, ... ... Graham BS, et al. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine. 29: 304-13. PMID 21034824 DOI: 10.1016/J.Vaccine.2010.10.037 |
0.499 |
|
| 2010 |
McLellan JS, Chen M, Chang JS, Yang Y, Kim A, Graham BS, Kwong PD. Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F. Journal of Virology. 84: 12236-44. PMID 20881049 DOI: 10.1128/Jvi.01579-10 |
0.397 |
|
| 2010 |
Jaoko W, Karita E, Kayitenkore K, Omosa-Manyonyi G, Allen S, Than S, Adams EM, Graham BS, Koup RA, Bailer RT, Smith C, Dally L, Farah B, Anzala O, Muvunyi CM, et al. Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa. Plos One. 5: e12873. PMID 20877623 DOI: 10.1371/Journal.Pone.0012873 |
0.369 |
|
| 2010 |
Ruckwardt TJ, Luongo C, Malloy AM, Liu J, Chen M, Collins PL, Graham BS. Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope. Journal of Immunology (Baltimore, Md. : 1950). 185: 4673-80. PMID 20833834 DOI: 10.4049/Jimmunol.1001606 |
0.371 |
|
| 2010 |
Rimoin AW, Mulembakani PM, Johnston SC, Lloyd Smith JO, Kisalu NK, Kinkela TL, Blumberg S, Thomassen HA, Pike BL, Fair JN, Wolfe ND, Shongo RL, Graham BS, Formenty P, Okitolonda E, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proceedings of the National Academy of Sciences of the United States of America. 107: 16262-7. PMID 20805472 DOI: 10.1073/Pnas.1005769107 |
0.38 |
|
| 2010 |
Graham BS, McElrath MJ, Keefer MC, Rybczyk K, Berger D, Weinhold KJ, Ottinger J, Ferarri G, Montefiori DC, Stablein D, Smith C, Ginsberg R, Eldridge J, Duerr A, Fast P, et al. Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity. Plos One. 5: e11995. PMID 20706632 DOI: 10.1371/Journal.Pone.0011995 |
0.354 |
|
| 2010 |
Liu J, Ruckwardt TJ, Chen M, Nicewonger JD, Johnson TR, Graham BS. Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection. Journal of Virology. 84: 10501-9. PMID 20686045 DOI: 10.1128/Jvi.00963-10 |
0.359 |
|
| 2010 |
Graham BS, Kines RC, Corbett KS, Nicewonger J, Johnson TR, Chen M, LaVigne D, Roberts JN, Cuburu N, Schiller JT, Buck CB. Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination. Mucosal Immunology. 3: 475-86. PMID 20555315 DOI: 10.1038/Mi.2010.31 |
0.353 |
|
| 2010 |
Rosenberg ES, Graham BS, Chan ES, Bosch RJ, Stocker V, Maenza J, Markowitz M, Little S, Sax PE, Collier AC, Nabel G, Saindon S, Flynn T, Kuritzkes D, Barouch DH, et al. Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection. Plos One. 5: e10555. PMID 20479938 DOI: 10.1371/Journal.Pone.0010555 |
0.389 |
|
| 2010 |
Freel SA, Lamoreaux L, Chattopadhyay PK, Saunders K, Zarkowsky D, Overman RG, Ochsenbauer C, Edmonds TG, Kappes JC, Cunningham CK, Denny TN, Weinhold KJ, Ferrari G, Haynes BF, Koup RA, ... Graham BS, et al. Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination. Journal of Virology. 84: 4998-5006. PMID 20200250 DOI: 10.1128/Jvi.00138-10 |
0.446 |
|
| 2010 |
Koup RA, Roederer M, Lamoreaux L, Fischer J, Novik L, Nason MC, Larkin BD, Enama ME, Ledgerwood JE, Bailer RT, Mascola JR, Nabel GJ, Graham BS. Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses. Plos One. 5: e9015. PMID 20126394 DOI: 10.1371/Journal.Pone.0009015 |
0.408 |
|
| 2010 |
McLellan JS, Chen M, Kim A, Yang Y, Graham BS, Kwong PD. Structural basis of respiratory syncytial virus neutralization by motavizumab. Nature Structural & Molecular Biology. 17: 248-50. PMID 20098425 DOI: 10.1038/Nsmb.1723 |
0.407 |
|
| 2010 |
Kibuuka H, Kimutai R, Maboko L, Sawe F, Schunk MS, Kroidl A, Shaffer D, Eller LA, Kibaya R, Eller MA, Schindler KB, Schuetz A, Millard M, Kroll J, Dally L, ... ... Graham BS, et al. A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172). The Journal of Infectious Diseases. 201: 600-7. PMID 20078213 DOI: 10.1086/650299 |
0.417 |
|
| 2010 |
Cheng C, Gall JG, Nason M, King CR, Koup RA, Roederer M, McElrath MJ, Morgan CA, Churchyard G, Baden LR, Duerr AC, Keefer MC, Graham BS, Nabel GJ. Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization. Journal of Virology. 84: 630-8. PMID 19846512 DOI: 10.1128/Jvi.00866-09 |
0.471 |
|
| 2009 |
Graham BS. What does the report of the USMHRP Phase III study in Thailand mean for HIV and for vaccine developers? Clinical and Experimental Immunology. 158: 257-9. PMID 19906099 DOI: 10.1111/J.1365-2249.2009.04055.X |
0.493 |
|
| 2009 |
Ledgerwood JE, Graham BS. DNA vaccines: a safe and efficient platform technology for responding to emerging infectious diseases. Human Vaccines. 5: 623-6. PMID 19779298 DOI: 10.4161/Hv.8627 |
0.422 |
|
| 2009 |
Graham BS, Ledgerwood JE, Nabel GJ. Vaccine development in the twenty-first century: Changing paradigms for elusive viruses Clinical Pharmacology and Therapeutics. 86: 234-236. PMID 19707212 DOI: 10.1038/Clpt.2009.128 |
0.417 |
|
| 2009 |
Johnson TR, Rao S, Seder RA, Chen M, Graham BS. TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity. Vaccine. 27: 3045-52. PMID 19428918 DOI: 10.1016/J.Vaccine.2009.03.026 |
0.371 |
|
| 2009 |
Sullivan NJ, Martin JE, Graham BS, Nabel GJ. Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule. Nature Reviews. Microbiology. 7: 393-400. PMID 19369954 DOI: 10.1038/Nrmicro2129 |
0.442 |
|
| 2009 |
Koup RA, Lamoreaux L, Zarkowsky D, Bailer RT, King CR, Gall JG, Brough DE, Graham BS, Roederer M. Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials. Journal of Virology. 83: 6318-22. PMID 19339347 DOI: 10.1128/Jvi.00384-09 |
0.365 |
|
| 2009 |
Davis KL, Gray ES, Moore PL, Decker JM, Salomon A, Montefiori DC, Graham BS, Keefer MC, Pinter A, Morris L, Hahn BH, Shaw GM. High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination. Virology. 387: 414-26. PMID 19298995 DOI: 10.1016/J.Virol.2009.02.022 |
0.395 |
|
| 2009 |
Liu J, Ruckwardt TJ, Chen M, Johnson TR, Graham BS. Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model. Journal of Virology. 83: 4934-41. PMID 19264776 DOI: 10.1128/Jvi.02140-08 |
0.319 |
|
| 2009 |
Cecchini S, Negrete A, Virag T, Graham BS, Cohen JI, Kotin RM. Evidence of prior exposure to human bocavirus as determined by a retrospective serological study of 404 serum samples from adults in the United States. Clinical and Vaccine Immunology : Cvi. 16: 597-604. PMID 19244471 DOI: 10.1128/Cvi.00470-08 |
0.37 |
|
| 2009 |
Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS. Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. Journal of Virology. 83: 3019-28. PMID 19153229 DOI: 10.1128/Jvi.00036-09 |
0.348 |
|
| 2009 |
Letvin N, Mascola J, Rao S, Buzby A, Roederer M, Hudgens M, Gilbert P, Seder R, Douek D, Koup R, Graham B, Nabel G. P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P421 |
0.417 |
|
| 2009 |
Johnson D, Merino Y, Berkowitz N, Vasilenko O, Larkin B, Young S, Graham B, Ledgerwood JM. P15-30 LB. An evaluation of prescreen recruitment data: Enrolling racial/ethnic minorities in Phase I HIV vaccine clinical trials Retrovirology. 6: P406. DOI: 10.1186/1742-4690-6-S3-P406 |
0.356 |
|
| 2009 |
Casazza JP, Bowman K, Adzaku S, Ambrozak DA, Roederer M, Bailer RT, Enama M, Nason M, Ledgerwood JE, Graham BS, Koup RA. P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen Retrovirology. 6: P315. DOI: 10.1186/1742-4690-6-S3-P315 |
0.367 |
|
| 2009 |
Sitar S, Hartman BI, Graham BS, Ledgerwood JE. P15-17. Social media as a tool for engaging and educating audiences around HIV vaccine research and clinical trial participation Retrovirology. 6: P218. DOI: 10.1186/1742-4690-6-S3-P218 |
0.313 |
|
| 2009 |
Enama ME, Novik L, Holman L, Gordon I, Nason M, Ledgerwood J, Graham BS. P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults Retrovirology. 6: P200. DOI: 10.1186/1742-4690-6-S3-P200 |
0.356 |
|
| 2009 |
Ledgerwood JE, Novik L, Enama ME, Gordon IJ, Holman LA, Nason MC, Bailer RT, Roederer M, Koup RA, Mascola JR, Nabel GJ, Graham BS. P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011) Retrovirology. 6: P198. DOI: 10.1186/1742-4690-6-S3-P198 |
0.36 |
|
| 2009 |
Freel SA, Chattopadhyay PK, Lamoreaux L, Zarkowsky D, Overman RG, Ochsenbauer-Jambor C, Kappes JC, Cunningham CK, Denny TN, Weinhold KJ, Ferrari G, Koup RA, Graham BS, Haynes BF, Roederer M, et al. S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers Retrovirology. 6: O1. DOI: 10.1186/1742-4690-6-S3-O1 |
0.317 |
|
| 2008 |
Martin JE, Louder MK, Holman LA, Gordon IJ, Enama ME, Larkin BD, Andrews CA, Vogel L, Koup RA, Roederer M, Bailer RT, Gomez PL, Nason M, Mascola JR, Nabel GJ, ... Graham BS, et al. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. Vaccine. 26: 6338-43. PMID 18824060 DOI: 10.1016/J.Vaccine.2008.09.026 |
0.437 |
|
| 2008 |
Johnson TR, Rothenberg ME, Graham BS. Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein. Journal of Leukocyte Biology. 84: 748-59. PMID 18519743 DOI: 10.1189/Jlb.0907621 |
0.354 |
|
| 2008 |
Nelson S, Jost CA, Xu Q, Ess J, Martin JE, Oliphant T, Whitehead SS, Durbin AP, Graham BS, Diamond MS, Pierson TC. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. Plos Pathogens. 4: e1000060. PMID 18464894 DOI: 10.1371/Journal.Ppat.1000060 |
0.442 |
|
| 2008 |
Shi W, Huang Y, Sutton-Smith M, Tissot B, Panico M, Morris HR, Dell A, Haslam SM, Boyington J, Graham BS, Yang ZY, Nabel GJ. A filovirus-unique region of Ebola virus nucleoprotein confers aberrant migration and mediates its incorporation into virions. Journal of Virology. 82: 6190-9. PMID 18417588 DOI: 10.1128/Jvi.02731-07 |
0.304 |
|
| 2008 |
Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis Journal of Virology. 82: 2040-2055. PMID 17928346 DOI: 10.1128/Jvi.01625-07 |
0.382 |
|
| 2007 |
Martin JE, Pierson TC, Hubka S, Rucker S, Gordon IJ, Enama ME, Andrews CA, Xu Q, Davis BS, Nason M, Fay M, Koup RA, Roederer M, Bailer RT, Gomez PL, ... ... Graham BS, et al. A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. The Journal of Infectious Diseases. 196: 1732-40. PMID 18190252 DOI: 10.1086/523650 |
0.472 |
|
| 2007 |
Eller MA, Eller LA, Opollo MS, Ouma BJ, Oballah PO, Galley L, Karnasuta C, Kim SR, Robb ML, Michael NL, Kibuuka H, Wabwire-Mangen F, Graham BS, Birx DL, de Souza MS, et al. Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans Vaccine. 25: 7737-7742. PMID 17920731 DOI: 10.1016/J.Vaccine.2007.08.056 |
0.385 |
|
| 2007 |
Precopio ML, Betts MR, Parrino J, Price DA, Gostick E, Ambrozak DR, Asher TE, Douek DC, Harari A, Pantaleo G, Bailer R, Graham BS, Roederer M, Koup RA. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. The Journal of Experimental Medicine. 204: 1405-16. PMID 17535971 DOI: 10.1084/Jem.20062363 |
0.451 |
|
| 2007 |
Catanzaro AT, Roederer M, Koup RA, Bailer RT, Enama ME, Nason MC, Martin JE, Rucker S, Andrews CA, Gomez PL, Mascola JR, Nabel GJ, Graham BS. Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine. Vaccine. 25: 4085-92. PMID 17391815 DOI: 10.1016/J.Vaccine.2007.02.050 |
0.422 |
|
| 2007 |
Tavel JA, Martin JE, Kelly GG, Enama ME, Shen JM, Gomez PL, Andrews CA, Koup RA, Bailer RT, Stein JA, Roederer M, Nabel GJ, Graham BS. Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 601-5. PMID 17325604 DOI: 10.1097/Qai.0B013E3180417Cb6 |
0.342 |
|
| 2007 |
Rutigliano JA, Ruckwardt TJ, Martin JE, Graham BS. Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection. Virology. 362: 314-9. PMID 17275872 DOI: 10.1016/J.Virol.2006.12.023 |
0.413 |
|
| 2007 |
Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 20: 108-19. PMID 17143259 DOI: 10.1038/Modpathol.3800725 |
0.389 |
|
| 2007 |
Parrino J, McCurdy LH, Larkin BD, Gordon IJ, Rucker SE, Enama ME, Koup RA, Roederer M, Bailer RT, Moodie Z, Gu L, Yan L, Graham BS. Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals Vaccine. 25: 1513-1525. PMID 17126963 DOI: 10.1016/J.Vaccine.2006.10.047 |
0.465 |
|
| 2007 |
Russell ND, Graham BS, Keefer MC, McElrath MJ, Self SG, Weinhold KJ, Montefiori DC, Ferrari G, Horton H, Tomaras GD, Gurunathan S, Baglyos L, Frey SE, Mulligan MJ, Harro CD, et al. Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 203-12. PMID 17106277 DOI: 10.1097/01.Qai.0000248356.48501.Ff |
0.413 |
|
| 2006 |
Parrino J, Graham BS. Smallpox vaccines: Past, present, and future Journal of Allergy and Clinical Immunology. 118: 1320-1326. PMID 17157663 DOI: 10.1016/J.Jaci.2006.09.037 |
0.436 |
|
| 2006 |
Zhou W, Hashimoto K, Moore ML, Elias JA, Zhu Z, Durbin J, Colasurdo G, Rutigliano JA, Chiappetta CL, Goleniewska K, O'Neal JF, Graham BS, Peebles RS. IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse. Microbes and Infection / Institut Pasteur. 8: 2880-9. PMID 17110149 DOI: 10.1016/J.Micinf.2006.09.007 |
0.335 |
|
| 2006 |
Graham BS, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Martin JE, McCluskey MM, Chakrabarti BK, Lamoreaux L, Andrews CA, Gomez PL, Mascola JR, Nabel GJ. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. The Journal of Infectious Diseases. 194: 1650-60. PMID 17109336 DOI: 10.1086/509259 |
0.397 |
|
| 2006 |
Catanzaro AT, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Gu L, Martin JE, Novik L, Chakrabarti BK, Butman BT, Gall JG, King CR, Andrews CA, Sheets R, ... ... Graham BS, et al. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. The Journal of Infectious Diseases. 194: 1638-49. PMID 17109335 DOI: 10.1086/509258 |
0.311 |
|
| 2006 |
Khurana S, Needham J, Park S, Mathieson B, Busch MP, Nemo G, Nyambi P, Zolla-Pazner S, Laal S, Mulenga J, Chomba E, Hunter E, Allen S, McIntyre J, Hewlett I, ... ... Graham BS, et al. Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes. Journal of Acquired Immune Deficiency Syndromes (1999). 43: 304-12. PMID 17019363 DOI: 10.1097/01.Qai.0000242465.50947.5F |
0.416 |
|
| 2006 |
Martin JE, Sullivan NJ, Enama ME, Gordon IJ, Roederer M, Koup RA, Bailer RT, Chakrabarti BK, Bailey MA, Gomez PL, Andrews CA, Moodie Z, Gu L, Stein JA, Nabel GJ, ... Graham BS, et al. A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial. Clinical and Vaccine Immunology : Cvi. 13: 1267-77. PMID 16988008 DOI: 10.1128/Cvi.00162-06 |
0.473 |
|
| 2006 |
Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hryniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, ... ... Graham BS, et al. Subunit recombinant vaccine protects against monkeypox Journal of Immunology. 177: 2552-2564. PMID 16888017 DOI: 10.4049/Jimmunol.177.4.2552 |
0.422 |
|
| 2006 |
Khurana S, Needham J, Mathieson B, Rodriguez-Chavez IR, Catanzaro AT, Bailer RT, Kim J, Polonis V, Cooper DA, Guerin J, Peterson ML, Gurwith M, Nguyen N, Graham BS, Golding H. Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies. Journal of Virology. 80: 2092-9. PMID 16474117 DOI: 10.1128/Jvi.80.5.2092-2099.2006 |
0.414 |
|
| 2006 |
Graham BS. New approaches to vaccine adjuvants: Inhibiting the inhibitor Plos Medicine. 3: 18-20. PMID 16383350 DOI: 10.1371/Journal.Pmed.0030057 |
0.384 |
|
| 2005 |
Hashimoto K, Durbin JE, Zhou W, Collins RD, Ho SB, Kolls JK, Dubin PJ, Sheller JR, Goleniewska K, O'Neal JF, Olson SJ, Mitchell D, Graham BS, Peebles RS. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. The Journal of Allergy and Clinical Immunology. 116: 550-7. PMID 16159623 DOI: 10.1016/J.Jaci.2005.03.051 |
0.367 |
|
| 2005 |
Rutigliano JA, Rock MT, Johnson AK, Crowe JE, Graham BS. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology. 337: 335-43. PMID 15916793 DOI: 10.1016/J.Virol.2005.04.032 |
0.381 |
|
| 2005 |
Gower TL, Pastey MK, Peeples ME, Collins PL, McCurdy LH, Hart TK, Guth A, Johnson TR, Graham BS. RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology. Journal of Virology. 79: 5326-36. PMID 15827147 DOI: 10.1128/Jvi.79.9.5326-5336.2005 |
0.792 |
|
| 2005 |
Graham BS, Mascola JR. Lessons from failure - Preparing for future HIV-1 vaccine efficacy trials Journal of Infectious Diseases. 191: 647-649. PMID 15688276 DOI: 10.1086/428406 |
0.419 |
|
| 2005 |
Graham BS. Clinical Trials of DNA and Recombinant Adenovector (rAd) Vaccines for HIV Retrovirology. 2: 1-1. DOI: 10.1186/1742-4690-2-S1-S61 |
0.353 |
|
| 2005 |
Martin J, Enama M, Koup R, Bailer R, Moodie Z, Roederer M, Nabel G, Graham B. VRC 004: Safety and Immunogenicity of a Multiclade HIV-1 DNA Vaccine in Healthy Uninfected Adults (VRC-HIVDNA009-00-VP) Journal of Allergy and Clinical Immunology. 115: 892. DOI: 10.1016/J.Jaci.2005.01.050 |
0.366 |
|
| 2004 |
Schmidt AC, Johnson TR, Openshaw PJ, Braciale TJ, Falsey AR, Anderson LJ, Wertz GW, Groothuis JR, Prince GA, Melero JA, Graham BS. Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003. Virus Research. 106: 1-13. PMID 15522442 DOI: 10.1016/J.Virusres.2004.06.008 |
0.414 |
|
| 2004 |
McCurdy LH, Rutigliano JA, Johnson TR, Chen M, Graham BS. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4. Journal of Virology. 78: 12471-9. PMID 15507634 DOI: 10.1128/Jvi.78.22.12471-12479.2004 |
0.479 |
|
| 2004 |
Hashimoto K, Graham BS, Geraci MW, FitzGerald GA, Egan K, Zhou W, Goleniewska K, O'Neal JF, Morrow JD, Durbin RK, Wright PF, Collins RD, Suzutani T, Peebles RS. Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness. Journal of Virology. 78: 10303-9. PMID 15367596 DOI: 10.1128/Jvi.78.19.10303-10309.2004 |
0.398 |
|
| 2004 |
Rutigliano JA, Graham BS. Prolonged production of TNF-α exacerbates illness during respiratory syncytial virus infection Journal of Immunology. 173: 3408-3417. PMID 15322205 DOI: 10.4049/Jimmunol.173.5.3408 |
0.434 |
|
| 2004 |
Lee D, Graham BS, Chiu YL, Gilbert PB, McElrath MJ, Belshe RB, Buchbinder SP, Sheppard HW, Koblin BA, Mayer KH, Keefer MC, Mulligan MJ, Celum CL. Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160. The Journal of Infectious Diseases. 190: 903-7. PMID 15295694 DOI: 10.1086/423284 |
0.408 |
|
| 2004 |
Johnson TR, Varga SM, Braciale TJ, Graham BS. Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV. Journal of Virology. 78: 8753-60. PMID 15280483 DOI: 10.1128/Jvi.78.16.8753-8760.2004 |
0.427 |
|
| 2004 |
Budge PJ, Graham BS. Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses. The Journal of Antimicrobial Chemotherapy. 54: 299-302. PMID 15254023 DOI: 10.1093/Jac/Dkh355 |
0.723 |
|
| 2004 |
McCurdy LH, Larkin BD, Martin JE, Graham BS. Modified vaccinia Ankara: Potential as an alternative smallpox vaccine Clinical Infectious Diseases. 38: 1749-1753. PMID 15227622 DOI: 10.1086/421266 |
0.396 |
|
| 2004 |
Johnson TR, Teng MN, Collins PL, Graham BS. Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV. Journal of Virology. 78: 6024-32. PMID 15141000 DOI: 10.1128/Jvi.78.11.6024-6032.2004 |
0.426 |
|
| 2004 |
Hashimoto K, Graham BS, Ho SB, Adler KB, Collins RD, Olson SJ, Zhou W, Suzutani T, Jones PW, Goleniewska K, O'Neal JF, Peebles RS. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5 American Journal of Respiratory and Critical Care Medicine. 170: 306-312. PMID 15130904 DOI: 10.1164/Rccm.200301-030Oc |
0.369 |
|
| 2004 |
Budge PJ, Li Y, Beeler JA, Graham BS. RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G. Journal of Virology. 78: 5015-22. PMID 15113882 DOI: 10.1128/Jvi.78.10.5015-5022.2004 |
0.74 |
|
| 2004 |
Rutigliano JA, Johnson TR, Hollinger TN, Fischer JE, Aung S, Graham BS. Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection. Journal of Virology. 78: 3014-23. PMID 14990720 DOI: 10.1128/Jvi.78.6.3014-3023.2004 |
0.663 |
|
| 2004 |
Johnson TR, Graham BS. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection. The Pediatric Infectious Disease Journal. 23: S46-57. PMID 14730270 DOI: 10.1097/01.Inf.0000108192.94692.D2 |
0.484 |
|
| 2003 |
Budge PJ, Lebowitz J, Graham BS. Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers. Antimicrobial Agents and Chemotherapy. 47: 3470-7. PMID 14576104 DOI: 10.1128/Aac.47.11.3470-3477.2003 |
0.695 |
|
| 2003 |
Peebles RS, Hashimoto K, Graham BS. The complex relationship between respiratory syncytial virus and allergy in lung disease Viral Immunology. 16: 25-34. PMID 12725686 DOI: 10.1089/088282403763635429 |
0.376 |
|
| 2003 |
Johnson TR, Parker RA, Johnson JE, Graham BS. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge. Journal of Immunology (Baltimore, Md. : 1950). 170: 2037-45. PMID 12574374 DOI: 10.4049/Jimmunol.170.4.2037 |
0.303 |
|
| 2003 |
McCurdy LH, Graham BS. Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation Journal of Virology. 77: 1747-1756. PMID 12525608 DOI: 10.1128/Jvi.77.3.1747-1756.2003 |
0.354 |
|
| 2002 |
Graham BS, Rutigliano JA, Johnson TR. Respiratory syncytial virus immunobiology and pathogenesis. Virology. 297: 1-7. PMID 12083830 DOI: 10.1006/Viro.2002.1431 |
0.408 |
|
| 2002 |
Hashimoto K, Peebles RS, Sheller JR, Jarzecka K, Furlong J, Mitchell DB, Hartert TV, Graham BS. Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor. Thorax. 57: 524-7. PMID 12037228 DOI: 10.1136/Thorax.57.6.524 |
0.347 |
|
| 2002 |
Johnson TR, Hong S, Van Kaer L, Koezuka Y, Graham BS. NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus. Journal of Virology. 76: 4294-303. PMID 11932395 DOI: 10.1128/Jvi.76.9.4294-4303.2002 |
0.373 |
|
| 2002 |
Wright PF, Gruber WC, Peters M, Reed G, Zhu Y, Robinson F, Coleman-Dockery S, Graham BS. Illness Severity, Viral Shedding, and Antibody Responses in Infants Hospitalized with Bronchiolitis Caused by Respiratory Syncytial Virus The Journal of Infectious Diseases. 185: 1011-1018. PMID 11930309 DOI: 10.1086/339822 |
0.421 |
|
| 2002 |
Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS. The role of IFN in respiratory syncytial virus pathogenesis. Journal of Immunology (Baltimore, Md. : 1950). 168: 2944-52. PMID 11884466 DOI: 10.4049/Jimmunol.168.6.2944 |
0.412 |
|
| 2002 |
Graham BS. Clinical trials of HIV vaccines Annual Review of Medicine. 53: 207-221. PMID 11818471 DOI: 10.1146/Annurev.Med.53.082901.104035 |
0.419 |
|
| 2002 |
Gupta K, Hudgens M, Corey L, McElrath MJ, Weinhold K, Montefiori DC, Gorse GJ, Frey SE, Keefer MC, Evans TG, Dolin R, Schwartz DH, Harro C, Graham B, Spearman PW, et al. Safety and Immunogenicity of a High-Titered Canarypox Vaccine in Combination With rgp120 in a Diverse Population of HIV-1–Uninfected Adults: AIDS Vaccine Evaluation Group Protocol 022A Jaids Journal of Acquired Immune Deficiency Syndromes. 29: 254-261. DOI: 10.1097/00042560-200203010-00005 |
0.403 |
|
| 2001 |
Bredenberg HK, Graham BS. Hospitalization costs of respiratory syncytial virus infection [1] Pediatric Infectious Disease Journal. 20: 1100-1101. PMID 11734726 DOI: 10.1097/00006454-200111000-00026 |
0.356 |
|
| 2001 |
Peebles RS, Hashimoto K, Collins RD, Jarzecka K, Furlong J, Mitchell DB, Sheller JR, Graham BS. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges. The Journal of Infectious Diseases. 184: 1374-9. PMID 11709778 DOI: 10.1086/324429 |
0.396 |
|
| 2001 |
Peebles RS, Graham BS. Viruses, dendritic cells and the lung Respiratory Research. 2: 245-249. PMID 11686890 DOI: 10.1186/Rr63 |
0.363 |
|
| 2001 |
Aung S, Rutigliano JA, Graham BS. Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease. Journal of Virology. 75: 9918-24. PMID 11559824 DOI: 10.1128/Jvi.75.20.9918-9924.2001 |
0.647 |
|
| 2001 |
Johnson TR, Fischer JE, Graham BS. Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine. The Journal of General Virology. 82: 2107-16. PMID 11514719 DOI: 10.1099/0022-1317-82-9-2107 |
0.482 |
|
| 2001 |
Gower TL, Peeples ME, Collins PL, Graham BS. RhoA is activated during respiratory syncytial virus infection. Virology. 283: 188-96. PMID 11336544 DOI: 10.1006/Viro.2001.0891 |
0.787 |
|
| 2001 |
Gower TL, Graham BS. Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro. Antimicrobial Agents and Chemotherapy. 45: 1231-7. PMID 11257039 DOI: 10.1128/Aac.45.4.1231-1237.2001 |
0.796 |
|
| 2001 |
Evans TG, McElrath MJ, Matthews T, Montefiori D, Weinhold K, Wolff M, Keefer MC, Kallas EG, Corey L, Gorse GJ, Belshe R, Graham BS, Spearman PW, Schwartz D, Mulligan MJ, et al. QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans. Vaccine. 19: 2080-91. PMID 11228380 DOI: 10.1016/S0264-410X(00)00415-1 |
0.342 |
|
| 2000 |
Fischer JE, Johnson JE, Johnson TR, Graham BS. Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection. The Journal of Infectious Diseases. 182: 1029-38. PMID 10979896 DOI: 10.1086/315806 |
0.422 |
|
| 2000 |
Graham BS, Johnson TR, Peebles RS. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology. 48: 237-47. PMID 10960663 DOI: 10.1016/S0162-3109(00)00233-2 |
0.487 |
|
| 2000 |
Peebles RS, Sheller JR, Collins RD, Jarzecka K, Mitchell DB, Graham BS. Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV. The Journal of Infectious Diseases. 182: 671-7. PMID 10950758 DOI: 10.1086/315783 |
0.47 |
|
| 2000 |
Aung S, Graham BS. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo. Journal of Immunology (Baltimore, Md. : 1950). 164: 3487-93. PMID 10725701 DOI: 10.4049/Jimmunol.164.7.3487 |
0.597 |
|
| 2000 |
Pastey MK, Gower TL, Spearman PW, Crowe JE, Graham BS. A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nature Medicine. 6: 35-40. PMID 10613821 DOI: 10.1038/71503 |
0.795 |
|
| 2000 |
Peebles RC, Sheller JR, Jarzecka AK, Mitchell DB, Graham BS. 867 RSV infection decreases type 2 cytokine concentrations during allergen sensitization, yet increases airway hyperresponsiveness in mice The Journal of Allergy and Clinical Immunology. 105. DOI: 10.1016/S0091-6749(00)91295-8 |
0.313 |
|
| 1999 |
Aung S, Tang YW, Graham BS. Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo. Journal of Virology. 73: 8944-9. PMID 10515999 DOI: 10.1128/Jvi.73.11.8944-8949.1999 |
0.628 |
|
| 1999 |
Johnson TR, Graham BS. Secreted respiratory syncytial virus G glycoprotein induces interleukin- 5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism Journal of Virology. 73: 8485-8495. PMID 10482601 DOI: 10.1128/Jvi.73.10.8485-8495.1999 |
0.326 |
|
| 1999 |
Fisher RG, Crowe JE, Johnson TR, Tang Y, Graham BS. Passive IgA Monoclonal Antibody Is No More Effective Than IgG at Protecting Mice from Mucosal Challenge with Respiratory Syncytial Virus The Journal of Infectious Diseases. 180: 1324-1327. PMID 10479165 DOI: 10.1086/315037 |
0.434 |
|
| 1999 |
Gicheru MM, Otsyula M, Spearman P, Graham BS, Miller CJ, Robinson HL, Haigwood NL, Montefiori DC. Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm) Journal of Medical Primatology. 28: 97-104. PMID 10475110 DOI: 10.1111/J.1600-0684.1999.Tb00257.X |
0.397 |
|
| 1999 |
Pastey MK, Crowe JE, Graham BS. RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation Journal of Virology. 73: 7262-7270. PMID 10438814 DOI: 10.1128/Jvi.73.9.7262-7270.1999 |
0.402 |
|
| 1999 |
Fischer JE, Johnson TR, Peebles RS, Graham BS. Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge Journal of Infectious Diseases. 180: 714-719. PMID 10438359 DOI: 10.1086/314947 |
0.433 |
|
| 1999 |
Fisher RG, Johnson JE, Dillon SB, Parker RA, Graham BS. Prophylaxis with respiratory syncytial virus F-specific humanized monoclonal antibody delays and moderately suppresses the native antibody response but does not impair immunity to late rechallenge Journal of Infectious Diseases. 180: 708-713. PMID 10438358 DOI: 10.1086/314965 |
0.442 |
|
| 1999 |
Evans TG, Keefer MC, Weinhold KJ, Wolff M, Montefiori D, Gorse GJ, Graham BS, McElrath MJ, Clements-Mann ML, Mulligan MJ, Fast P, Walker MC, Excler JL, Duliege AM, Tartaglia J. A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. The Journal of Infectious Diseases. 180: 290-8. PMID 10395842 DOI: 10.1086/314895 |
0.424 |
|
| 1999 |
Peebles RS, Sheller JR, Johnson JE, Mitchell DB, Graham BS. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice. Journal of Medical Virology. 57: 186-92. PMID 9892406 DOI: 10.1002/(Sici)1096-9071(199902)57:2<186::Aid-Jmv17>3.0.Co;2-Q |
0.368 |
|
| 1998 |
Graham BS. Science, medicine, and the future: Infection with HIV-1 British Medical Journal. 317: 1297-1301. PMID 9804721 DOI: 10.1136/Bmj.317.7168.1297 |
0.357 |
|
| 1998 |
Clements-Mann ML, Weinhold K, Matthews TJ, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Hsieh RH, Mestecky J, Zolla-Pazner S, Mascola J, Schwartz D, Siliciano R, Corey L, Wright PF, et al. Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. The Journal of Infectious Diseases. 177: 1230-46. PMID 9593008 DOI: 10.1086/515288 |
0.413 |
|
| 1998 |
Johnson TR, Johnson JE, Roberts SR, Wertz GW, Parker RA, Graham BS. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge Journal of Virology. 72: 2871-2880. PMID 9525607 DOI: 10.1128/Jvi.72.4.2871-2880.1998 |
0.345 |
|
| 1998 |
Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, et al. Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. The Journal of Infectious Diseases. 177: 310-9. PMID 9466516 DOI: 10.1086/514209 |
0.475 |
|
| 1998 |
Corey L, McElrath MJ, Weinhold K, Matthews T, Stablein D, Graham B, Keefer M, Schwartz D, Gorse G. Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group. The Journal of Infectious Diseases. 177: 301-9. PMID 9466515 DOI: 10.1086/514202 |
0.457 |
|
| 1998 |
Connor RI, Korber BTM, Graham BS, Hahn BH, Ho DD, Walker BD, Neumann AU, Vermund SH, Mestecky J, Jackson S, Fenamore E, Cao Y, Gao F, Kalams S, Kunstman KJ, et al. Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines Journal of Virology. 72: 1552-1576. PMID 9445059 DOI: 10.1128/Jvi.72.2.1552-1576.1998 |
0.5 |
|
| 1997 |
Fischer JE, Johnson JE, Kuli-Zade RK, Johnson TR, Aung S, Parker RA, Graham BS. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. Journal of Virology. 71: 8672-7. PMID 9343225 DOI: 10.1128/Jvi.71.11.8672-8677.1997 |
0.628 |
|
| 1997 |
Tang YW, Neuzil KM, Fischer JE, Robinson FW, Parker RA, Graham BS. Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus Vaccine. 15: 597-602. PMID 9178456 DOI: 10.1016/S0264-410X(96)00214-9 |
0.451 |
|
| 1997 |
Neuzil KM, Johnson JE, Tang Y, Prieels J, Slaoui M, Gar N, Graham BS. Adjuvants influence the quantitative and qualitative immune response in BALBc mice immunized with respiratory syncytial virus FG subunit vaccine Vaccine. 15: 525-532. PMID 9160520 DOI: 10.1016/S0264-410X(97)00218-1 |
0.471 |
|
| 1997 |
Tang YW, Graham BS. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice Journal of Clinical Investigation. 99: 2183-2191. PMID 9151790 DOI: 10.1172/Jci119391 |
0.451 |
|
| 1997 |
Neuzil KM, Gruber WC, Graham BS. Vitamin A therapy for respiratory syncytial virus infection [3] Pediatric Infectious Disease Journal. 16: 84-85. PMID 9002114 DOI: 10.1097/00006454-199701000-00024 |
0.365 |
|
| 1996 |
Graham BS. Immunological determinants of disease caused by respiratory syncytial virus Trends in Microbiology. 4: 290-294. PMID 8829339 DOI: 10.1016/0966-842X(96)10032-9 |
0.453 |
|
| 1996 |
Keefer MC, Graham BS, McElrath MJ, Matthews TJ, Stablein DM, Corey L, Wright PF, Lawrence D, Fast PE, Weinhold K, Hsieh RH, Chernoff D, Dekker C, Dolin R. Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group. Aids Research and Human Retroviruses. 12: 683-93. PMID 8744579 DOI: 10.1089/Aid.1996.12.683 |
0.39 |
|
| 1996 |
Graham BS, Keefer MC, McElrath MJ, Gorse GJ, Schwartz DH, Weinhold K, Matthews TJ, Esterlitz JR, Sinangil F, Fast PE. Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group. Annals of Internal Medicine. 125: 270-9. PMID 8678389 DOI: 10.7326/0003-4819-125-4-199608150-00003 |
0.429 |
|
| 1996 |
Neuzil KM, Tang YW, Graham BS. Protective role of TNF-α in respiratory syncytial virus infection in vitro and in vivo American Journal of the Medical Sciences. 311: 201-204. PMID 8615393 DOI: 10.1097/00000441-199605000-00001 |
0.375 |
|
| 1996 |
Mascola JR, Snyder SW, Weislow OS, Belay SM, Belshe RB, Schwartz DH, Clements ML, Dolin R, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Walker MC, Wagner KF, McNeil JG, et al. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. The Journal of Infectious Diseases. 173: 340-8. PMID 8568294 DOI: 10.1093/Infdis/173.2.340 |
0.444 |
|
| 1996 |
Tang YW, Graham BS. Potential for directing appropriate responses to vaccines by cytokine manipulation Clinical Immunotherapeutics. 5: 327-333. DOI: 10.1007/Bf03259330 |
0.422 |
|
| 1996 |
Neuzil KM, Graham BS. Cytokine release and innate immunity in respiratory viral infection Seminars in Virology. 7: 255-264. DOI: 10.1006/Smvy.1996.0032 |
0.426 |
|
| 1995 |
Graham BS, Tang YW, Gruber WC. Topical immunoprophylaxis of respiratory syncytial virus (rsv)-challenged mice with rsv-specific immune globulin Journal of Infectious Diseases. 171: 1468-1474. PMID 7769280 DOI: 10.1093/Infdis/171.6.1468 |
0.433 |
|
| 1995 |
Tang VW, Graham BS. Interleukin-12 treatment during immunization elicits a t helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity Journal of Infectious Diseases. 172: 734-738. PMID 7658066 DOI: 10.1093/Infdis/172.3.734 |
0.393 |
|
| 1995 |
Neuzil KM, Gruber WC, Chytil F, Stahlman MT, Graham BS. Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections. Antimicrobial Agents and Chemotherapy. 39: 1191-3. PMID 7625814 DOI: 10.1128/Aac.39.5.1191 |
0.352 |
|
| 1995 |
Graham BS, Wright PF. Candidate AIDS vaccines New England Journal of Medicine. 333: 1331-1339. PMID 7566026 DOI: 10.1056/Nejm199511163332007 |
0.383 |
|
| 1995 |
Graham BS. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology American Journal of Respiratory and Critical Care Medicine. 152. PMID 7551416 DOI: 10.1164/Ajrccm/152.4_Pt_2.S63 |
0.488 |
|
| 1995 |
Walker MC, Fast PE, Graham BS, Belshe R, Dolin R. Phase I/II preventive vaccine trials: Conference summary Aids Research and Human Retroviruses. 11: 1279-1285. DOI: 10.1089/Aid.1995.11.1279 |
0.335 |
|
| 1994 |
Neuzil KM, Gruber WC, Chytil F, Stahlman MT, Engelhardt B, Graham BS. Serum vitamin A levels in respiratory syncytial virus infection. The Journal of Pediatrics. 124: 433-6. PMID 8120715 DOI: 10.1016/S0022-3476(94)70369-8 |
0.389 |
|
| 1994 |
Belshe RB, Clements ML, Keefer MC, Graham BS, Corey L, Sposto R, Wescott S, Lawrence D. Interpreting HIV serodiagnostic test results in the 1990s: Social risks of HIV vaccine studies in uninfected volunteers Annals of Internal Medicine. 121: 584-589. PMID 8085690 DOI: 10.7326/0003-4819-121-8-199410150-00005 |
0.381 |
|
| 1994 |
Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM. Binding of human immunodeficiency virus type i to the c3b/c4b receptor crt (cd35) and red blood cells in the presence of envelope-specific antibodies and complement Journal of Infectious Diseases. 170: 429-432. PMID 8035031 DOI: 10.1093/infdis/170.2.429 |
0.302 |
|
| 1994 |
Tang YW, Graham BS. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus Journal of Clinical Investigation. 94: 1953-1958. PMID 7962541 DOI: 10.1172/Jci117546 |
0.39 |
|
| 1994 |
Gorse GJ, Schwartz DH, Graham BS, Matthews TJ, Stablein DM, Frey SE, Belshe RB, Clements ML, Wright PF, Eibl M. HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network. Clinical and Experimental Immunology. 98: 178-84. PMID 7955519 DOI: 10.1111/J.1365-2249.1994.Tb06122.X |
0.421 |
|
| 1994 |
Belshe RB, Gorse GJ, Graham BS, Wright P, Keefer MC, Dolin R, Matthews T, Weinhold K, Bolognesi DP, Sposto R, Stablein DM, Twaddell T, Berman PW, Gregory T, Izu AE, et al. Neutralizing Antibodies to HIV-1 in Seronegative Volunteers Immunized With Recombinant gp 120 From the MN Strain of HIV-1 Jama: the Journal of the American Medical Association. 272: 475-480. PMID 7913731 DOI: 10.1001/JAMA.272.6.475 |
0.379 |
|
| 1994 |
Keefer MC, Graham BS, Belshe RB, Schwartz D, Corey L, Bolognesi DP, Stablein DM, Montefiori DC, McElrath MJ, Clements ML. Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network. Aids Research and Human Retroviruses. 10: 1713-23. PMID 7888231 DOI: 10.1089/Aid.1994.10.1713 |
0.41 |
|
| 1993 |
Edwards KM, Decker MD, Graham BS, Mezzatesta J, Scott J, Hackell J. Adult Immunization With Acellular Pertussis Vaccine Jama: the Journal of the American Medical Association. 269: 53-56. PMID 8416406 DOI: 10.1001/Jama.1993.03500010063032 |
0.413 |
|
| 1993 |
Hesselton RM, Koup RA, Cromwell MA, Graham BS, Johns M, Sullivan JL. Human Peripheral Blood Xenografts in the SCID Mouse: Characterization of Immunologic Reconstitution Journal of Infectious Diseases. 168: 630-640. PMID 8354904 DOI: 10.1093/Infdis/168.3.630 |
0.312 |
|
| 1993 |
Montefiori DC, Graham BS, Zhou J, Zhou J, Bucco RA, Schwartz DH, Cavacini LA, Posner MR. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network. The Journal of Clinical Investigation. 92: 840-7. PMID 8349820 DOI: 10.1172/Jci116658 |
0.392 |
|
| 1993 |
Belshe RB, Clements ML, Dolin R, Graham BS, McElrath J, Gorse GJ, Schwartz D, Keefer MC, Wright P, Corey L, Bolognesi DP, Matthews TJ, Stablein DM, Brien FSO, Eibl M, et al. Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection Journal of Infectious Diseases. 168: 1387-1395. PMID 8245523 DOI: 10.1093/Infdis/168.6.1387 |
0.464 |
|
| 1993 |
Graham BS, Davis TH, Tang YW, Gruber WC. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum. Pediatric Research. 34: 167-72. PMID 8233720 DOI: 10.1203/00006450-199308000-00013 |
0.432 |
|
| 1993 |
Pincus SH, Messer KG, Schwartz DH, Lewis GK, Graham BS, Blattner WA, Fisher G. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees. The Journal of Clinical Investigation. 91: 1987-96. PMID 7683694 DOI: 10.1172/Jci116420 |
0.458 |
|
| 1992 |
Lindgren C, Jing L, Graham B, Grögaard J, Sundell H. Respiratory syncytial virus infection reinforces reflex apnea in young lambs. Pediatric Research. 31: 381-5. PMID 1570205 DOI: 10.1203/00006450-199204000-00015 |
0.374 |
|
| 1992 |
Ukwu HN, Graham BS, Lambert JS, Wright PF. Perinatal transmission of human immunodeficiency virus-1 infection and maternal immunization strategies for prevention Obstetrics and Gynecology. 80: 458-468. PMID 1495707 DOI: 10.1016/0020-7292(93)90725-C |
0.379 |
|
| 1992 |
Graham BS. Clinical trials of AIDS vaccines in seronegative volunteers: Vectors and combinations Aids Research and Human Retroviruses. 8: 1327-1328. PMID 1466951 DOI: 10.1089/Aid.1992.8.1327 |
0.364 |
|
| 1992 |
Graham BS, Belshe RB, Clements ML, Dolin R, Corey L, Wright PF, Gorse GJ, Midthun K, Keefer MC, Roberts NJ, Schwartz DH, Agosti JM, Fernie BF, Stablein DM, Montefiori DC, et al. Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial Journal of Infectious Diseases. 166: 244-252. PMID 1353102 DOI: 10.1093/Infdis/166.2.244 |
0.479 |
|
| 1992 |
Montefiori DC, Graham BS, Kliks S, Wright PF. Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160 Journal of Clinical Immunology. 12: 429-439. PMID 1287035 DOI: 10.1007/Bf00918855 |
0.416 |
|
| 1991 |
Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, Karzon DT, Bonnez W, Fernie BF, Montefiori DC, Stablein DM, et al. The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans Annals of Internal Medicine. 114: 119-127. PMID 1984386 DOI: 10.7326/0003-4819-114-2-119 |
0.426 |
|
| 1991 |
Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice Journal of Clinical Investigation. 88: 1026-1033. PMID 1909350 DOI: 10.1172/Jci115362 |
0.376 |
|
| 1991 |
Graham BS, Bunton LA, Rowland J, Wright PF, Karzon DT. Respiratory syncytial virus infection in anti-μ-treated mice Journal of Virology. 65: 4936-4942. PMID 1908028 DOI: 10.1128/Jvi.65.9.4936-4942.1991 |
0.419 |
|
| 1991 |
Graham BS, Bunton LA, Wright PF, Karzon DT. Reinfection of mice with respiratory syncytial virus Journal of Medical Virology. 34: 7-13. PMID 1885946 DOI: 10.1002/Jmv.1890340103 |
0.353 |
|
| 1990 |
Graham BS, Rowland JM, Modliszewski A, Montefiori DC. Antifusion activity in sera from persons infected with human immunodeficiency virus type 1. Journal of Clinical Microbiology. 28: 2608-11. PMID 2279989 DOI: 10.1128/Jcm.28.12.2608-2611.1990 |
0.436 |
|
| 1988 |
Hendry RM, Burns JC, Walsh EE, Graham BS, Wright PF, Hemming VG, Rodriguez WJ, Kim HW, Prince GA, McIntosh K, Chanock RM, Murphy BR. Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus Journal of Infectious Diseases. 157: 640-647. PMID 3346563 DOI: 10.1093/Infdis/157.4.640 |
0.382 |
|
| 1988 |
Graham BS, Perkins MD, Wright PF, Karzon DT. Primary respiratory syncytial virus infection in mice Journal of Medical Virology. 26: 153-162. PMID 3183639 DOI: 10.1002/Jmv.1890260207 |
0.367 |
|
| 1986 |
Murphy BR, Alling DW, Snyder MH, Walsh EE, Prince GA, Chanock RM, Hemming VG, Rodriguez WJ, Kim HW, Graham BS. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. Journal of Clinical Microbiology. 24: 894-8. PMID 3771779 DOI: 10.1128/Jcm.24.5.894-898.1986 |
0.379 |
|
| 1986 |
Wagner DK, Graham BS, Wright PF, Walsh EE, Kim HW, Reimer CB, Nelson DL, Chanock RM, Murphy BR. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. Journal of Clinical Microbiology. 24: 304-6. PMID 3755731 DOI: 10.1128/Jcm.24.2.304-306.1986 |
0.411 |
|
| 1986 |
Murphy BR, Graham BS, Prince GA, Walsh EE, Chanock RM, Karzon DT, Wright PF. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. Journal of Clinical Microbiology. 23: 1009-14. PMID 3754878 DOI: 10.1128/Jcm.23.6.1009-1014.1986 |
0.38 |
|
| 1983 |
Graham BS, Reiss TF, Gregory DW. Pericarditis associated with Hemophilus influenzae type B pneumonia and bacteremia in two adults Chest. 84: 48-50. PMID 6602694 DOI: 10.1378/Chest.84.1.48 |
0.319 |
|
| Show low-probability matches. |